<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7463108\results\search\disease\results.xml">
  <result pre="critical to examine the mechanisms underlying pathophysiologic interactions between human" exact="immunodeficiency" post="virus (HIV) and opioids in the central nervous system"/>
  <result pre="interactions between human immunodeficiency virus (HIV) and opioids in the" exact="central nervous system" post="(CNS). Recent advances in experimental models, methodology, and our"/>
  <result pre="Recent advances in experimental models, methodology, and our understanding of" exact="disease" post="processes at the molecular and cellular levels reveal opioid-HIV"/>
  <result pre="in unique structural or functional deficits not seen with either" exact="disease" post="alone. These considerations include, understanding the combined consequences of"/>
  <result pre="selectively increases the expression of some efflux transporters, thereby restricting" exact="brain" post="penetration of specific drugs. Keywords Antiretroviral therapy Astrocyte Blood-brain"/>
  <result pre="2016 (Scholl et al. 2018; UNODC 2019c). The Centers of" exact="Disease" post="Control and Prevention (CDC) reports that on average 130"/>
  <result pre="2017). Injection drug use increases the likelihood of contracting human" exact="immunodeficiency" post="virus (HIV) and drug abuse and HIV have long"/>
  <result pre="increases the likelihood of contracting human immunodeficiency virus (HIV) and" exact="drug abuse" post="and HIV have long been described as interrelated epidemics"/>
  <result pre="Leshner 1998; Nath et al. 1999, 2002). Despite this understanding," exact="opioid use disorder" post="(OUD) and HIV remain a huge public health concern"/>
  <result pre="1998; Nath et al. 1999, 2002). Despite this understanding, opioid" exact="use disorder" post="(OUD) and HIV remain a huge public health concern"/>
  <result pre="infection, social-distancing practices create isolation, despair, and economic hardships, heightening" exact="opioid abuse" post="(with inherent respiratory depression depending on the amount of"/>
  <result pre="isolation, despair, and economic hardships, heightening opioid abuse (with inherent" exact="respiratory" post="depression depending on the amount of tolerance developed) and"/>
  <result pre="despair, and economic hardships, heightening opioid abuse (with inherent respiratory" exact="depression" post="depending on the amount of tolerance developed) and the"/>
  <result pre="than morphine, easily smuggled, and frequently and inconsistently mixed with" exact="lower" post="quality drugs increasing the probability of overdosing. According to"/>
  <result pre="(UNODC 2019b). The Pathophysiology of Opioid Abuse The effects of" exact="opioid abuse" post="on the central nervous system (CNS) have been extensively"/>
  <result pre="of Opioid Abuse The effects of opioid abuse on the" exact="central nervous system" post="(CNS) have been extensively examined. Immediate effects of opioids"/>
  <result pre="2002; Bourne and Mills 2004; Qureshi and Lee-Chiong 2004). While" exact="acute" post="opioid exposure can impair cognition in healthy subjects (Lawlor"/>
  <result pre="subjects (Lawlor 2002; Ersek et al. 2004), enduring cognitive and" exact="psychomotor" post="deficits occur with chronic opioid use (Sjogren et al."/>
  <result pre="et al. 2004), enduring cognitive and psychomotor deficits occur with" exact="chronic" post="opioid use (Sjogren et al. 2000; Dublin et al."/>
  <result pre="altered DNA methylation and expression of non-coding RNAs) alterations in" exact="brain" post="regions implicated in mood, reward, and motivation (Upadhyay et"/>
  <result pre="to 90% of post-mortem tissues sampled from opiate abusers display" exact="brain edema" post="(Buttner 2011), astrogliosis and microgliosis especially in the hippocampus"/>
  <result pre="more, studies report neurovascular disorders, hypoxic ischemic leukoencephalopathy, and region-specific" exact="atrophy" post="with neuronal losses that can include the hippocampal formation,"/>
  <result pre="report neurovascular disorders, hypoxic ischemic leukoencephalopathy, and region-specific atrophy with" exact="neuronal" post="losses that can include the hippocampal formation, the cerebellar"/>
  <result pre="by postmortem reports of smaller mean relative volumes in various" exact="brain" post="regions in individuals with OUD, including cortical areas (Danos"/>
  <result pre="volumes in various brain regions in individuals with OUD, including" exact="cortical" post="areas (Danos et al. 1998; Pezawas et al. 1998),"/>
  <result pre="al. 2014), and hypothalamus (Muller et al. 2018). Interestingly, leukoencephalopathy," exact="atrophy" post="(Cadet et al. 2014), and increased hyperphosphorylated tau-containing neurofibrillary"/>
  <result pre="2014), and increased hyperphosphorylated tau-containing neurofibrillary tangles are reported with" exact="chronic" post="opiate abuse compared to age-matched controls (Ramage et al."/>
  <result pre="2005; Anthony et al. 2010; Kovacs et al. 2015) and" exact="cognitive impairment" post="(Gruber et al. 2007). Moreover, heroin use is associated"/>
  <result pre="typical actions of opiates, which by themselves (and in the" exact="absence of" post="a priming event such as HIV co-exposure) tend to"/>
  <result pre="physical dependence. How opioids effect neuroHIV, as well as how" exact="opioid abuse" post="and dependence are altered by neuroHIV or whether opioid-HIV"/>
  <result pre="by neuroHIV or whether opioid-HIV interactions result in a unique" exact="disease" post="state are discussed. HIV Neuropathology in the Context of"/>
  <result pre="are discussed. HIV Neuropathology in the Context of Opioid Use" exact="Disorder" post="â€&quot; Clinical and Preclinical Evidence Preclinical and Clinical Findingsâ€&quot;a"/>
  <result pre="Disorder â€&quot; Clinical and Preclinical Evidence Preclinical and Clinical Findingsâ€&quot;a" exact="Complicated" post="Picture People infected with HIV (PWH) with OUD have"/>
  <result pre="of HIV. PWH who develop intractable pain syndromes related to" exact="peripheral" post="neuropathies often receive opioid drugs for treatment (Mirsattari et"/>
  <result pre="cofactor hypothesisâ€� proposes opioids contribute directly to the pathogenesis of" exact="acquired immune deficiency syndrome" post="(AIDS) (Donahoe and Vlahov 1998), in part, because MOR"/>
  <result pre="proposes opioids contribute directly to the pathogenesis of acquired immune" exact="deficiency" post="syndrome (AIDS) (Donahoe and Vlahov 1998), in part, because"/>
  <result pre="opioids contribute directly to the pathogenesis of acquired immune deficiency" exact="syndrome" post="(AIDS) (Donahoe and Vlahov 1998), in part, because MOR"/>
  <result pre="the pre-cART era, opiate abuse was found to exacerbate HIV" exact="encephalitis" post="(HIVE) (Bell et al. 1998, 2002). In Indonesian injection"/>
  <result pre="in the rate of death from AIDS, reduced incidence of" exact="opportunistic infections" post="and HIVE, and a 40â€&quot;50% decrease in the incidence"/>
  <result pre="the rate of death from AIDS, reduced incidence of opportunistic" exact="infections" post="and HIVE, and a 40â€&quot;50% decrease in the incidence"/>
  <result pre="and HIVE, and a 40â€&quot;50% decrease in the incidence of" exact="HIV-associated dementia" post="(HAD), the most severe form of HIV-associated neurocognitive disorders"/>
  <result pre="HIVE, and a 40â€&quot;50% decrease in the incidence of HIV-associated" exact="dementia" post="(HAD), the most severe form of HIV-associated neurocognitive disorders"/>
  <result pre="2000; McArthur et al. 2010; Saylor et al. 2016). Nevertheless," exact="chronic" post="opiate exposure (which almost always is confounded by the"/>
  <result pre="2005; Bell et al. 2006; Anthony et al. 2008) and" exact="cognitive impairment" post="(Rodriguez Salgado et al. 2006; Martin-Thormeyer and Paul 2009;"/>
  <result pre="2019). Opiate exposure in cART-treated PWH worsens CD4 counts and" exact="viral" post="loads (Ryan et al. 2004), neuropathology (including increased tauopathy;"/>
  <result pre="cART â€¢ SUD â€¢ Prescription opioids for pain â€¢ â†‘" exact="Viral" post="load with SUD â€¢ â†&quot; ARV adherence â€¢ â†‘"/>
  <result pre="(Denis et al. 2019) HIV cART OUD â€¢ â†&quot; Lasting" exact="viral" post="suppression â€¢ â†&quot; Adherence to cART for 3Â years"/>
  <result pre="use â†&quot; CD4 counts Human (Meijerink et al. 2014) HIV" exact="encephalitis" post="(HIVE) HIV infection CNS HIV ZDV Former drug use"/>
  <result pre="CD4 counts Human (Meijerink et al. 2014) HIV encephalitis (HIVE)" exact="HIV infection" post="CNS HIV ZDV Former drug use (+ OST) â€¢"/>
  <result pre="counts Human (Meijerink et al. 2014) HIV encephalitis (HIVE) HIV" exact="infection" post="CNS HIV ZDV Former drug use (+ OST) â€¢"/>
  <result pre="â†‘ Multinucleated giant cells â€¢ â†‘ HIV p24 Human, postmortem" exact="brain" post="(Bell et al. 1998) Microglial activation HIV â€¢ ARV"/>
  <result pre="CD68 microglial activation only in non-OUD HIV+ PWH Human, postmortem" exact="brain" post="(Smith et al. 2014) HIV â€¢ ARV â€¢ ZDV,"/>
  <result pre="â€¢ â†‘ MHC class II â€¢ â†‘ CD68 Human, postmortem" exact="brain" post="(Anthony et al. 2005) HIV No info OUD (44%"/>
  <result pre="OUD â€¢ No effect of IDU on CD68 Human, postmortem" exact="brain" post="(Byrd et al. 2012) Plasma cytokines HIV cART OUD"/>
  <result pre="inflammatory infiltrates â€¢ â†‘ HIV PCR amplification products Human, postmortem" exact="brain" post="(Gosztonyi et al. 1993) Aberrant immune responses HIV No"/>
  <result pre="alcohol, marijuana, cocaine) (+ OST) â€¢ â†‘ Autoantibodies and delayed" exact="hypersensitivity" post="to neural antigens OUD only â€¢ No HIV effect/interaction"/>
  <result pre="1991) Learning-memory HIV 50-70% on cART Heroin, crack/cocaine â€¢ â†&quot;" exact="Total" post="learning; â†&quot; Learning slope â€¢ â†&quot; Delayed recall Human,"/>
  <result pre="crack/cocaine â€¢ â†&quot; Total learning; â†&quot; Learning slope â€¢ â†&quot;" exact="Delayed" post="recall Human, female (Meyer et al. 2013) HIV cART"/>
  <result pre="Total learning; â†&quot; Learning slope â€¢ â†&quot; Delayed recall Human," exact="female" post="(Meyer et al. 2013) HIV cART Reported heroin use"/>
  <result pre="HIV No info SUD (opioids, alcohol, marijuana, cocaine) â€¢ â†&quot;" exact="Complex" post="figure copy â€¢ â†&quot; Delayed recall Human (Concha et"/>
  <result pre="alcohol, marijuana, cocaine) â€¢ â†&quot; Complex figure copy â€¢ â†&quot;" exact="Delayed" post="recall Human (Concha et al. 1997) Neuropsychological performance cART"/>
  <result pre="HIV No info OUD (+ OST, methadone) â€¢ â†‘ Pattern-shift" exact="visual" post="evoked potential delay with methadone â€¢ No HIV effect/interaction"/>
  <result pre="injection â€¢ â†‘ On ARV Human (Pettes et al. 2010)" exact="Motor" post="and visual function HIV No info OST â€¢ â†&quot;"/>
  <result pre="â†‘ On ARV Human (Pettes et al. 2010) Motor and" exact="visual" post="function HIV No info OST â€¢ â†&quot; Digital Finger-Tapping"/>
  <result pre="Motor and visual function HIV No info OST â€¢ â†&quot;" exact="Digital" post="Finger-Tapping test â€¢ â†&quot; Visual motor pursuit Human (Silberstein"/>
  <result pre="â†&quot; DRD2L correlates with â†‘ cognitive performance Human, post mortem" exact="brain" post="(Gelman et al. 2012) OPRM1 polymorphisms, splice variants HIV"/>
  <result pre="not CXCR4, CCR5 or CD4 receptor in HIVE Human, postmortem" exact="brain" post="(Dever et al. 2014) OPRK and PDYN polymorphisms HIV"/>
  <result pre="/ response to ARV Human (Proudnikov et al. 2013) Sensory" exact="Neuropathy" post="HIV cART SUD HIV sensory neuropathy- regardless of SUD"/>
  <result pre="2010) Preclinical in vivo findings (animal) HIV entry into the" exact="brain" post="Mixture of SIV17-EFr, SHIVKU_1B, SHIV89.6P No Morphine (5Â mg/kg"/>
  <result pre="(5Â mg/kg i.m., b.i.d., â‰¤ 56Â weeks) â€¢ â†‘ CSF" exact="viral" post="load â€¢ â†‘ Viral migration through BBB for SHIVKU"/>
  <result pre="â‰¤ 56Â weeks) â€¢ â†‘ CSF viral load â€¢ â†‘" exact="Viral" post="migration through BBB for SHIVKU Rhesus macaques (Kumar et"/>
  <result pre="â€¢ â†‘ CD4+ and CD8+ T cells â€¢ â†‘ CSF" exact="viral" post="load â€¢ â†‘ Infiltration of MDMs into the brain"/>
  <result pre="CSF viral load â€¢ â†‘ Infiltration of MDMs into the" exact="brain" post="Rhesus macaques (Bokhari et al. 2011). Viral load and"/>
  <result pre="MDMs into the brain Rhesus macaques (Bokhari et al. 2011)." exact="Viral" post="load and HIV progression Mixture of SIV17-EFr, SHIVKU _1B,"/>
  <result pre="No Morphine (5Â mg/kg, i.m., t.i.d., 20Â weeks) â€¢ â†‘" exact="Viral" post="load; â†&quot; CD4 counts â€¢ â†‘ ROS with morphine"/>
  <result pre="No Morphine (5Â mg/kg, i.m., t.i.d., 20â€&quot;56Â weeks) â€¢ â†‘" exact="Viral" post="load; â†&quot; CD4 counts â€¢ tat evolutionâ€&quot;inverse correlation with"/>
  <result pre="and Kumar 2006; Noel et al. 2006b) nef â€¢ â†‘" exact="Viral" post="load; â†&quot; CD4 counts â€¢ â†&quot; nef evolution; no"/>
  <result pre="progression Â± morphine (Noel et al. 2006a) env â€¢ â†‘" exact="Viral" post="load; â†&quot; CD4 counts â€¢ â†‘ env evolution (V4"/>
  <result pre="with morphine (Noel and Kumar 2007; Rivera et al. 2013)" exact="Neuronal" post="injury, survival, oxidative stress gp120 HIV-1LAV No Morphine (25Â"/>
  <result pre="days) â€¢ â†‘ ROS during withdrawal â€¢ â†&quot; PSD95 during" exact="chronic" post="and withdrawal â€¢ â†‘ Sphingomyelin â€¢ â†&quot; Ceramide Mouse,"/>
  <result pre="5Â days) â†&quot; neuron survival HIV tgâ€‰+â€‰morphine Rat, HIV-1 tg," exact="female" post="(Guo et al. 2012) SIV HIV Tat No Morphine"/>
  <result pre="neuron survival with CM from morphine-treated astrocytes Rhesus macaques; Ratb," exact="primary" post="neurons, astrocytes (Hu et al. 2012) Synaptic transmission Tat1â€&quot;86"/>
  <result pre="Tat â†‘ HSPA5 mRNA (in vitro) Rhesus macaques; Human, SH-SY5Y" exact="neuroblastoma" post="cells in vitro (Pendyala et al. 2015) White matter"/>
  <result pre="(3Â mg/kg i.m., q.i.d., â‰¤ 59Â weeks) â€¢ â†‘ Focal," exact="demyelinating" post="lesions â€¢ â†‘ Macrophages in areas of myelin loss"/>
  <result pre="in macrophages/microglia â€¢ CCL2-knockout blocks morphine + Tat-induced glial reactivity" exact="Mouse" post="(El-Hage et al. 2008a) Cytokines, Chemokines HIV Tat (10Â"/>
  <result pre="mg pellet, 6Â days) â€¢ Morphine â†‘ death in Tatâ€‰+â€‰bacterial" exact="infection" post="â€¢ â†‘ TNFÎ±, IL-6, CCL2, â€¢ â†‘ TLR2, TLR4,"/>
  <result pre="CCR5 blockade Mouse, Tat tg, males (Gonek et al. 2018)" exact="Neuropathy" post="gp120 (0.2Â Î¼g), q.d. intrathecally No Morphine (3Â Î¼g,"/>
  <result pre="(escalating doses of 1â€&quot;2.5Â mg/kg i.m., q.i.d., 59Â weeks) â†&quot;" exact="Motor" post="skill Rhesus macaques (Marcario et al. 2016) Tat1â€&quot;86 No"/>
  <result pre="(25Â mg pellet, 5Â days) â†‘ Dextran extravasation across the" exact="blood-brain barrier" post="Mouse, Tat tg females (Leibrand et al. 2019) Immune"/>
  <result pre="T cell CXCR4 and CCR5 expression with morphine Mouse, CNS" exact="infection" post="(S. pneumoniae), males (Dutta and Roy 2015) ARV accumulation"/>
  <result pre="Tat1â€&quot;86 No Morphine (25Â mg pellet, last 5Â days) â†&quot;" exact="Total" post="wheel-running activity Mouse, Tat tg, males (Duncan et al."/>
  <result pre="trend that was not significant ABC, abacavir; ARV, antiretroviral(s); BBB," exact="blood-brain barrier;" post="b.i.d., twice a day; Brd4, Bromodomain-containing protein 4; CPu,"/>
  <result pre="twice a day; Brd4, Bromodomain-containing protein 4; CPu, caudate-putamen; CNS," exact="central nervous system;" post="CPP, conditioned place preference; CM, conditioned medium; CSF, cerebrospinal"/>
  <result pre="conditioned medium; CSF, cerebrospinal fluid; DAMGO [D-Ala2, N-MePhe4, Gly-ol]-enkephalin; DRD2L," exact="type 2" post="dopamine receptor; DTG, dolutegravir; HIVE, HIV encephalitis (typically seen"/>
  <result pre="Gly-ol]-enkephalin; DRD2L, type 2 dopamine receptor; DTG, dolutegravir; HIVE, HIV" exact="encephalitis" post="(typically seen pre-cART); HSPA5, heat shock 70-kDa protein A"/>
  <result pre="information not provided or uncertain; OST, opioid substitution therapy; OUD," exact="opioid use disorder;" post="PFC, prefrontal cortex; PENK, preproenkephalin; q.d., once a day;"/>
  <result pre="not provided or uncertain; OST, opioid substitution therapy; OUD, opioid" exact="use disorder;" post="PFC, prefrontal cortex; PENK, preproenkephalin; q.d., once a day;"/>
  <result pre="times a day; ROS, reactive oxygen species; s.c., subcutaneous; SUD," exact="substance use disorder;" post="tg, transgenic; t.i.d., three times a day; ZDV, zidovudine"/>
  <result pre="a day; ROS, reactive oxygen species; s.c., subcutaneous; SUD, substance" exact="use disorder;" post="tg, transgenic; t.i.d., three times a day; ZDV, zidovudine"/>
  <result pre="day; ZDV, zidovudine For practicality, Tables 1 and 2 are" exact="limited" post="to key studies in the CNS with emphasis on"/>
  <result pre="studies we excluded: (1) on opioid and HIV effects on" exact="peripheral" post="blood mononuclear cells (PBMCs), or on isolated lymphocytes and"/>
  <result pre="on isolated lymphocytes and monocytes, not directly related to the" exact="central nervous system" post="or BBB; (2) on HIV or opioid and ARV"/>
  <result pre="(2) on HIV or opioid and ARV interactions in the" exact="peripheral" post="nervous system; and (3) studies not directly examining opioid-HIV"/>
  <result pre="and multiple preclinical models are essential to better understand complex" exact="disease" post="and improve established therapies (Singer 2019). Evidence suggests that"/>
  <result pre="compartmentalizes within the CNS early during the course of the" exact="infection" post="establishing a separate reservoir harboring â€œintact proviralâ€� HIV (Churchill"/>
  <result pre="Volsky 2015). Preclinical studies assessing opioid interactions with HIV or" exact="viral" post="proteins permit mechanistic understanding of how particular CNS cell"/>
  <result pre="pharmacology of the opioid drug involved, the cell types and" exact="brain" post="regions targeted, host and viral genetics, and are highly"/>
  <result pre="involved, the cell types and brain regions targeted, host and" exact="viral" post="genetics, and are highly contextual (Hauser and Knapp 2014,"/>
  <result pre="â€¢ KOR agonists Â± TNF-Î± differentially â†&quot; HIV p24 Human," exact="primary" post="mixed neurons and glia (Chao et al. 1998a) Chemokines"/>
  <result pre="CCL2 â€¢ â†‘ [Ca2+]i (Beclin1 dependent) â€¢ â†&quot; Autophagy Mouse," exact="primary" post="mixed glia (Lapierre et al. 2018) HIVSF162 (R5) No"/>
  <result pre="ligand in astrocytes) â€¢ â†‘ IL-6 â€¢ â†‘ CCL5 Human," exact="primary" post="mixed glia (El-Hage et al. 2013) Glial restricted precursors:"/>
  <result pre="or morphine via DOR, KOR â€¢ No opioid-Tat interactions Mouse," exact="primary" post="glial precursors (Buch et al. 2007) MOR expression in"/>
  <result pre="of NPCs â€¢ â†‘ Astrocyte and immature glial death Mouse," exact="primary" post="mixed glia (Khurdayan et al. 2004) MOR and CCR5"/>
  <result pre="and CCR5 interactions Tat1â€&quot;86 (from HIVIIIB) No Morphine â€¢ â†&quot;" exact="Neuronal" post="survival via CCR5 activation in glia (rescued by BDNF"/>
  <result pre="via CCR5 activation in glia (rescued by BDNF treatment) Mouse," exact="primary" post="neurons and glia (Kim et al. 2018) HIV infectivity"/>
  <result pre="Morphine CCR5-MOR bivalent ligand 1b â€¢ MOR-CCR5 bivalent ligand blocks" exact="HIV infection" post="in astroglia, but not microglia, with morphine â€¢ MOR-CCR5"/>
  <result pre="CCR5-MOR bivalent ligand 1b â€¢ MOR-CCR5 bivalent ligand blocks HIV" exact="infection" post="in astroglia, but not microglia, with morphine â€¢ MOR-CCR5"/>
  <result pre="the fusion of HIV gp160 and CCR5-CD4-expressing HEK cells Human," exact="primary" post="astrocytes and microglia; HEK-293T cells (Yuan et al. 2013;"/>
  <result pre="â€¢ â†&quot; Proliferation of neural progenitors; â†‘ astroglial and â†‘" exact="neuronal" post="differentiation Human, neural progenitors (Balinang et al. 2017) Astrocytes"/>
  <result pre="No Morphine â€¢ â†‘ HIV p24 â€¢ â†‘ CCL2 Human," exact="primary" post="astrocytes (Rodriguez et al. 2017) Toll-like receptor (TLR) expression/function"/>
  <result pre="Tatâ€‰+â€‰morphine, gp120 â€¢ â†&quot; TLR9 with Tat, morphine, gp120 Mouse," exact="primary" post="astrocytes (El-Hage et al. 2011a) Chemokines Tat1â€&quot;72 No Morphine"/>
  <result pre="â†‘ CCL5, CCL2 â€¢ â†‘ IL-6 â€¢ â†‘ [Ca2+]i Mouse," exact="primary" post="astrocytes (El-Hage et al. 2005) Tat1â€&quot;72 No Morphine â€¢"/>
  <result pre="â†‘ CCL2 â€¢ â†‘ CCL5 â€¢ â†‘ Microglial migration Mouse," exact="primary" post="astrocytes (El-Hage et al. 2006a) Tat1â€&quot;72 No Morphine â€¢"/>
  <result pre="and transcription â€¢ No interaction / acceleration with morphine Mouse," exact="primary" post="astrocytes (El-Hage et al. 2008b) Tat No â€¢ U50,488"/>
  <result pre="antagonist) â€¢ U50,488 â†&quot; CCL2 â€¢ U50,488 â†&quot; NF-ÎºB Human," exact="primary" post="astrocytes (Sheng et al. 2003) N/A No Morphine â€¢"/>
  <result pre="â€¢ â†‘ CCR5, CCR3, CXCR2 â€¢ â†&quot; IL-8, CCL4 Human," exact="astrocytoma" post="U87 cell line, primary astrocytes (Mahajan et al. 2002)"/>
  <result pre="CXCR2 â€¢ â†&quot; IL-8, CCL4 Human, astrocytoma U87 cell line," exact="primary" post="astrocytes (Mahajan et al. 2002) â€¢ Tat1â€&quot;86 â€¢ gp120IIIB"/>
  <result pre="in cytokine and ROS production â€&quot;differed for each insult Mouse," exact="primary" post="astrocytes (Fitting et al. 2010a) Oxidative stress / damage"/>
  <result pre="(DOR agonists) DOR agonists â†&quot; Tat-induced oxidative stress Human derived" exact="brain" post="cell line (SK-N-SH) (Wallace et al. 2006) Inflammation, maturation"/>
  <result pre="Endomorphin-1 acts via MOR, but not DOR / KOR Human," exact="primary" post="microglia (Peterson et al. 1999) HIVSF162 (R5) No Morphine"/>
  <result pre="al. 1999) HIVSF162 (R5) No Morphine â†‘ HIV p24 Human," exact="primary" post="microglia (El-Hage et al. 2014) HIVSF162 (R5) No â€¢"/>
  <result pre="U69,593 (KOR agonists) â€¢ Dynorphin Al-13 â†&quot; HIV p24 Human," exact="primary" post="microglia (Chao et al. 1996b) â€¢ HIVJR-FL (R5) â€¢"/>
  <result pre="antagonists â€¢ KOR agonist negates cocaine-induced â†‘ HIV Human, fetal" exact="brain" post="microglia (Gekker et al. 2004) HIVSF162 No OPRL1 antisense"/>
  <result pre="â†&quot; p24 â€¢ Nociceptin, no effect on p24 Human, fetal" exact="brain" post="microglia and mixed neurons/glia (Chao et al. 1998b) HIV"/>
  <result pre="â†‘ IL-6, â†‘ IP-10 â€¢ â†‘ iNOS Mouse, BV-2 and" exact="primary" post="microglia (Bokhari et al. 2009) MOR signaling Tat1â€&quot;72 No"/>
  <result pre="â†‘ MOR (intracellular) â€¢ â†‘ MOR mRNA Mouse, N9 and" exact="primary" post="microglia (Turchan-Cholewo et al. 2008) Oxidative Stress Tat1â€&quot;72 No"/>
  <result pre="â†‘ ROS [O2âˆ’ (DHE), â†‘ HO2â€¢, H2O2 (DCF)] â€¢ â†‘" exact="Protein" post="carbonyls Mouse, N9 and primary microglia (Turchan-Cholewo et al."/>
  <result pre="HO2â€¢, H2O2 (DCF)] â€¢ â†‘ Protein carbonyls Mouse, N9 and" exact="primary" post="microglia (Turchan-Cholewo et al. 2009) Glutamate release Tat1â€&quot;72 No"/>
  <result pre="â†‘ Glutamate release via â†‘ xcâˆ’ cystine-glutamate antiporter expression/function Mouse," exact="primary" post="microglia (Gupta et al. 2010) Neurons HIV expression HIV"/>
  <result pre="expression HIV No Morphine â†‘ HIV expression Human derived, SH-SY5Y" exact="neuroblastoma" post="cells (Squinto et al. 1990) Homeostasis and Injury Tat1â€&quot;86"/>
  <result pre="â€¢ â†&quot; Î&quot;Î¨m (mitochondrial) instability â€¢ â†‘ Dendritic degeneration Mouse," exact="primary" post="neurons (Fitting et al. 2014a) Mitochondrial inner membrane potential"/>
  <result pre="â†‘ Dendritic degeneration Mouse, primary neurons (Fitting et al. 2014a)" exact="Mitochondrial" post="inner membrane potential and ROS â€¢ Tat1â€&quot;86, Tat1â€&quot;72 â€¢"/>
  <result pre="oxidative stress â†‘ with Tatâ€‰+â€‰morphine, â†‘ neuroprotection with allopregnanolone Human," exact="primary" post="neurons ; mouse, striatal medium spiny neurons; mouse, striatal"/>
  <result pre="striatal medium spiny neurons; mouse, striatal medium spiny neurons, SH-SY5Y" exact="neuroblastoma" post="cells (Turchan-Cholewo et al. 2006; Paris et al. 2020)"/>
  <result pre="neuroblastoma cells (Turchan-Cholewo et al. 2006; Paris et al. 2020)" exact="Neuronal" post="survival Tat1â€&quot;86 No Morphine â€¢ â†&quot; Neuronal survival from"/>
  <result pre="et al. 2020) Neuronal survival Tat1â€&quot;86 No Morphine â€¢ â†&quot;" exact="Neuronal" post="survival from Tatâ€‰+â€‰morphine and â†&quot; glial CX3CL1 rescued by"/>
  <result pre="rescued by CX3CL â€¢ CX3CL1 (fractalkine) regulates microglial motility Mouse," exact="primary" post="neurons and mixed glia (Suzuki et al. 2011) Tat1â€&quot;86"/>
  <result pre="and p21 â€¢ â†&quot; Cyclin D1 and Akt levels Human," exact="neuronal" post="precursors (Malik et al. 2014) Tat1â€&quot;72, Tat1â€&quot;86 No Morphine"/>
  <result pre="(Malik et al. 2014) Tat1â€&quot;72, Tat1â€&quot;86 No Morphine â€¢ â†&quot;" exact="Neuronal" post="survival â€¢ â†‘ Neuronal survival with ibudilast (AV411) (inhibiting"/>
  <result pre="Tat1â€&quot;72, Tat1â€&quot;86 No Morphine â€¢ â†&quot; Neuronal survival â€¢ â†‘" exact="Neuronal" post="survival with ibudilast (AV411) (inhibiting glial NF-ÎºB blocks Tatâ€‰Â±â€‰morphine"/>
  <result pre="with ibudilast (AV411) (inhibiting glial NF-ÎºB blocks Tatâ€‰Â±â€‰morphine neurotoxicity) Mouse," exact="primary" post="neurons and mixed glia (Gurwell et al. 2001; El-Hage"/>
  <result pre="al. 2014) White matter/oligodendroglial pathology Changes in OL survival and" exact="morphology" post="Tat1â€&quot;86 No Morphine (25Â mg pellet, 7Â days); morphine"/>
  <result pre="â†‘ TUNEL reactivity â€¢ â†‘ Caspase-3 activation Mouse, Tat tg;" exact="primary" post="OLs (Hauser et al. 2009) Blood-brain barrier and the"/>
  <result pre="â†‘ IL-8 â€¢ â†&quot;TEER â€¢ â†‘ JAM-2 expression â€¢ â†‘" exact="Monocyte" post="transmigration with CCL5 Human, using primary BMVEC and primary"/>
  <result pre="JAM-2 expression â€¢ â†‘ Monocyte transmigration with CCL5 Human, using" exact="primary" post="BMVEC and primary astrocytes (Mahajan et al. 2008) ARV"/>
  <result pre="â†‘ Monocyte transmigration with CCL5 Human, using primary BMVEC and" exact="primary" post="astrocytes (Mahajan et al. 2008) ARV accumulation Tat1â€&quot;86 DTG"/>
  <result pre="DTG FTC TFV Morphine â€¢ â†&quot; Intracellular ARV concentrations Human," exact="primary" post="astrocytes (Patel et al. 2019) HIV-1 strain differences Neuronal"/>
  <result pre="Human, primary astrocytes (Patel et al. 2019) HIV-1 strain differences" exact="Neuronal" post="Survival Tat1â€&quot;86 (clades B &amp;amp; C) No Morphine â€¢"/>
  <result pre="Survival Tat1â€&quot;86 (clades B &amp;amp; C) No Morphine â€¢ â†&quot;" exact="Neuronal" post="survival via MOR on mixed glia â€¢ â†‘ ROS"/>
  <result pre="astrocytes â€¢ â†‘ Iba1 and 3-NT microglia with morphine Mouse," exact="primary" post="neurons and mixed glia (Zou et al. 2011) â€¢"/>
  <result pre="gp120IIIB â€¢ gp120MN (X4) â€¢ gp120ADA (R5) No Morphine â†&quot;" exact="Neuronal" post="survival in presence of glia with gp120MN and transiently"/>
  <result pre="gp120IIIB (X4), not R5-tropic gp120, in combination with morphine Mouse," exact="primary" post="neurons and mixed glia (Podhaizer et al. 2012) Proliferation"/>
  <result pre="DNA synthesis with X4-tropic HIVâ€‰+â€‰morphine Mouse, Tat tg; Mouse, Human," exact="primary" post="neural progenitors (Hahn et al. 2012) GABA function â€¢"/>
  <result pre="prevents Tat and R5 HIV, gp120, but not X4, gp120" exact="neurotoxicity" post="Â± morphine Human, primary neurons, hNPCs (Barbour et al."/>
  <result pre="HIV, gp120, but not X4, gp120 neurotoxicity Â± morphine Human," exact="primary" post="neurons, hNPCs (Barbour et al. 2020) Astroglial CCL5 and"/>
  <result pre="Î¼M) â€¢ DAMGO â€¢ Morphine â†‘ astroglial CCL5 blocking gp120BaL" exact="neurotoxicity" post="â€¢ Morphine (or CXCL12) does not block gp120IIIB neurotoxicity"/>
  <result pre="gp120BaL neurotoxicity â€¢ Morphine (or CXCL12) does not block gp120IIIB" exact="neurotoxicity" post="Rat, mixed neurons and glia; isolated neurons, astrocytes and"/>
  <result pre="statistical findings for some results are unclear ARV, antiretroviral(s); BMVEC," exact="brain" post="vascular endothelial cells; [Ca2+]i intracellular calcium concentration; 8-CAC, 8-carboxamidocyclazocine;"/>
  <result pre="findings for some results are unclear ARV, antiretroviral(s); BMVEC, brain" exact="vascular" post="endothelial cells; [Ca2+]i intracellular calcium concentration; 8-CAC, 8-carboxamidocyclazocine; DAMGO,"/>
  <result pre="GABA, Î³-aminobutyric acid; Iba1, ionized calcium-binding adapter molecule 1; JAM-1," exact="junctional" post="adhesion molecule-1; KCC2, K+-Clâˆ’ cotransporter 2; KOR, Îº-opioid receptor;"/>
  <result pre="nick end labeling; ZDV, zidovudine For practicality, the table is" exact="limited" post="to key studies in the CNS with emphasis on"/>
  <result pre="on isolated lymphocytes and monocytes, not directly related to the" exact="central nervous system" post="or BBB; (2) on HIV or opioid and ARV"/>
  <result pre="(2) on HIV or opioid and ARV interactions in the" exact="peripheral" post="nervous system; and (3) studies not directly examining opioid-HIV"/>
  <result pre="in Astroglia Although the extent to which astroglia display productive" exact="infection" post="is debated (Russell et al. 2017; Ko et al."/>
  <result pre="of PWH (Gorry et al. 2003; Churchill et al. 2009)," exact="infectious" post="animal models (Eugenin et al. 2011), and/or cultured human"/>
  <result pre="HIV and opiate exposure, including HIV-1 replication, cytokine release, and" exact="neurotoxicity" post="in vitro (El-Hage et al. 2014). Thus, the observed"/>
  <result pre="neurotoxicity in vitro (El-Hage et al. 2014). Thus, the observed" exact="neuronal" post="death is largely mediated by MOR-expressing glia (Zou et"/>
  <result pre="cystine-glutamate antiporter xcâˆ’ (xCT) (Gupta et al. 2010). Interestingly, following" exact="acute" post="increases in the release of cytokines (e.g., TNF-Î±; unpublished),"/>
  <result pre="Opioid and HIV Interactive Pathology in Neurons Besides accentuating HIV-induced" exact="neurotoxicity" post="via glial-mediated mechanisms, morphine appears to converge with HIV"/>
  <result pre="cannot be excluded in this study (Fitting et al. 2014a)." exact="Combined" post="morphine and Tat exposure accelerates the formation of Tat-induced"/>
  <result pre="Combined morphine and Tat exposure accelerates the formation of Tat-induced" exact="focal" post="dendritic varicosities/swelling via a MOR-related mechanism that was caused"/>
  <result pre="dendritic varicosities/swelling via a MOR-related mechanism that was caused by" exact="focal" post="increases in Na+ influx and [Ca2+]i, an overload of"/>
  <result pre="and [Ca2+]i, an overload of Na+/K+-ATPase, ATP depletion, and a" exact="collapse" post="in mitochondrial inner membrane potential (Fitting et al. 2014a)."/>
  <result pre="TLR4 involvement (Fitting et al. 2014a). Further, morphine exacerbated Tat-dependent" exact="focal" post="losses in ion homeostasis by mobilizing [Ca2+]i through ryanodine-2"/>
  <result pre="#pÂ Â§pÂ c) Summary of HIV-1 Tat and morphine interactive" exact="neuronal" post="injury in striatal medium spiny neurons. Combined Tat and"/>
  <result pre="and morphine interactive neuronal injury in striatal medium spiny neurons." exact="Combined" post="Tat and morphine promotes structural and functional defects in"/>
  <result pre="and reprinted with permission from Fitting et al. (2014a) Glial-derived" exact="neuronal" post="injury is not unidirectional. Neuronal damage-associated molecular patterns (DAMPs)"/>
  <result pre="Fitting et al. (2014a) Glial-derived neuronal injury is not unidirectional." exact="Neuronal" post="damage-associated molecular patterns (DAMPs) and dysfunction can trigger both"/>
  <result pre="infected and uninfected glia to become reactive, resulting in further" exact="neuronal" post="damage and escalating pathology. Neuronal injury can reactivate HIV"/>
  <result pre="become reactive, resulting in further neuronal damage and escalating pathology." exact="Neuronal" post="injury can reactivate HIV in latently infected microglia (Alvarez-Carbonell"/>
  <result pre="HIV, little is known about their interactive effects on the" exact="blood-brain barrier" post="(BBB). BBB integrity and function are critical for maintaining"/>
  <result pre="of drug efflux proteins, such as P-glycoprotein (P-gp). Sub-chronic and" exact="chronic" post="morphine exposure is reported to increase P-gp expression and/or"/>
  <result pre="2019). Alternatively, other investigators report no changes in P-gp with" exact="chronic" post="exposure (Chaves et al. 2016), while some see increases"/>
  <result pre="efficacy of therapeutic drugs that are their substrates. Using a" exact="primary" post="human brain microvascular endothelial cell (BMEC) and astrocyte co-culture"/>
  <result pre="therapeutic drugs that are their substrates. Using a primary human" exact="brain" post="microvascular endothelial cell (BMEC) and astrocyte co-culture model, Mahajan"/>
  <result pre="leakage of fluorescently labeled dextrans from the circulation into the" exact="brain" post="(Leibrand et al. 2017, 2019) (Fig.Â 3). Morphine exposure"/>
  <result pre="HIV-1 Tat and morphine on BBB leakiness and on antiretroviral" exact="brain" post="concentrations. After 14 days of Tat induction, there was"/>
  <result pre="in the 10Â kDa (Cascade BlueÂ®) tracer leakage into the" exact="brain" post="in Tatâ€‰+â€‰placebo as compared to Tatâ€‰âˆ’â€‰placebo mice (*pÂ pÂ"/>
  <result pre="reprinted with permission from Leibrand et al. (2019) HIV, HIV-1" exact="viral" post="proteins, and opiate-induced barrier dysfunction is associated with increased"/>
  <result pre="of monocyte-derived macrophages (MDMs) into the brain. Enhanced influx of" exact="peripheral" post="(infected) macrophages into the brain can serve to replenish"/>
  <result pre="the brain. Enhanced influx of peripheral (infected) macrophages into the" exact="brain" post="can serve to replenish viral reservoirs and further promote"/>
  <result pre="peripheral (infected) macrophages into the brain can serve to replenish" exact="viral" post="reservoirs and further promote neuroinflammation. Several studies have examined"/>
  <result pre="examined the individual impact of HIV, Tat, or morphine on" exact="monocyte" post="adhesion or migration into the CNS (Nottet et al."/>
  <result pre="Tat and morphine or buprenorphine to a BBB model increases" exact="monocyte" post="transmigration in response to CCL5 and other chemokines (Mahajan"/>
  <result pre="and/or Tat exposure significantly enhances immune cell trafficking into the" exact="brain" post="via actions at TLR2 and TLR4 (Dutta and Roy"/>
  <result pre="cellular adhesion proteins, increased leakage of circulating molecules into the" exact="brain" post="and increased monocyte/MDM adhesion and transmigration into the brain,"/>
  <result pre="into the brain, which if infected, can serve to replenish" exact="viral" post="reservoirs within the CNS. Furthermore, alterations in drug transport"/>
  <result pre="the CNS. Furthermore, alterations in drug transport proteins within the" exact="brain" post="can decrease ARV efficacy by decreasing drug concentrations. Collectively,"/>
  <result pre="by decreasing drug concentrations. Collectively, these changes serve to maintain" exact="HIV infection" post="within the brain (see Fig.Â 4; TablesÂ 1 and"/>
  <result pre="decreasing drug concentrations. Collectively, these changes serve to maintain HIV" exact="infection" post="within the brain (see Fig.Â 4; TablesÂ 1 and"/>
  <result pre="Collectively, these changes serve to maintain HIV infection within the" exact="brain" post="(see Fig.Â 4; TablesÂ 1 and 2). Fig. 4"/>
  <result pre="TablesÂ 1 and 2). Fig. 4 Schematic representation of the" exact="blood-brain barrier" post="and other components of the neurovascular unit. Under normal"/>
  <result pre="opiate exposure increases efflux transporter expression, including P-gp and potentially" exact="breast cancer" post="resistance protein (Bcrp), thereby restricting overall brain penetration of"/>
  <result pre="exposure increases efflux transporter expression, including P-gp and potentially breast" exact="cancer" post="resistance protein (Bcrp), thereby restricting overall brain penetration of"/>
  <result pre="and potentially breast cancer resistance protein (Bcrp), thereby restricting overall" exact="brain" post="penetration of drugs (like many antiretroviral drugs) which are"/>
  <result pre="Correa et al. 2015). White matter deficits are associated with" exact="cognitive impairment," post="including shortfalls in memory (Ragin et al. 2005), executive"/>
  <result pre="(Wu et al. 2006; Stubbe-Drger et al. 2012), and perhaps" exact="depression" post="(Schmaal and van Velzen 2019). Preclinical studies in simian"/>
  <result pre="depression (Schmaal and van Velzen 2019). Preclinical studies in simian" exact="immunodeficiency" post="virus- (SIV-) infected rhesus macaques (Marcario et al. 2008)"/>
  <result pre="Injury to oligodendrocytes (OLs) can occur very early in the" exact="disease" post="(see review, Liu et al. 2016b). Viral proteins, including"/>
  <result pre="early in the disease (see review, Liu et al. 2016b)." exact="Viral" post="proteins, including Tat, gp120, and Nef, have been implicated"/>
  <result pre="and indirect actions. OLs lack CD4, and reports of OL" exact="infection" post="by HIV are variable (Esiri et al. 1991; Albright"/>
  <result pre="1991; Albright et al. 1996; Wohlschlaeger et al. 2009); thus," exact="HIV infection" post="of OLs is unlikely a major avenue of OL"/>
  <result pre="Albright et al. 1996; Wohlschlaeger et al. 2009); thus, HIV" exact="infection" post="of OLs is unlikely a major avenue of OL"/>
  <result pre="the degree of myelin disruption correlates with the duration of" exact="opiate dependence" post="(Ivers et al. 2018). Chronic oxycodone exposure in rats"/>
  <result pre="with the duration of opiate dependence (Ivers et al. 2018)." exact="Chronic" post="oxycodone exposure in rats causes some axonopathies and reduces"/>
  <result pre="in rats causes some axonopathies and reduces the size of" exact="axonal" post="fascicles, decreases myelin basic protein levels, and causes the"/>
  <result pre="al. 2000; Knapp et al. 2001; Stiene-Martin et al. 2001)." exact="Selective" post="MOR and possibly KOR activation can directly modulate the"/>
  <result pre="Despite long-standing evidence of white matter damage early during the" exact="infection" post="even in asymptomatic PWH (Price et al. 1988; Gray"/>
  <result pre="affects OLs and myelin in neuroHIV (Tables 1 and 2)." exact="Increased" post="demyelination is reported in SIV-infected rhesus macaques chronically treated"/>
  <result pre="Tornatore et al. 1994; Barat et al. 2018) can harbor" exact="HIV infection" post="(reviewed by Hauser and Knapp 2014; Putatunda et al."/>
  <result pre="et al. 1994; Barat et al. 2018) can harbor HIV" exact="infection" post="(reviewed by Hauser and Knapp 2014; Putatunda et al."/>
  <result pre="the degree to which they are a source of active" exact="infection" post="or serve as a latent viral reservoir (Blankson et"/>
  <result pre="a source of active infection or serve as a latent" exact="viral" post="reservoir (Blankson et al. 2002; Bruner et al. 2019)"/>
  <result pre="macroglial progeny is uncertain. In fact, spurious reports of HIV-infected" exact="adult" post="neurons (Torres-Munoz et al. 2001; Canto-Nogues et al. 2005)"/>
  <result pre="R5-tropic HIVBaL-infected hNPCs to morphine continuously for 21 d increased" exact="viral" post="production compared to HIVBaL infection alone in vitro (Balinang"/>
  <result pre="continuously for 21 d increased viral production compared to HIVBaL" exact="infection" post="alone in vitro (Balinang et al. 2017). Besides being"/>
  <result pre="of neural stem cells. That HIV or gp120 can inhibit" exact="adult" post="neurogenesis (Okamoto et al. 2007; Lee et al. 2013;"/>
  <result pre="and survival of neural progenitors/stem cells or the genesis of" exact="adult" post="neurons in the subgranular zone (SGZ) of the dentate"/>
  <result pre="2005; Li and Ransohoff 2008)] are proposed to modulate the" exact="adult" post="neurogenesis via Notch (Fan et al. 2016), by obstructing"/>
  <result pre="of the developing CNS through similar mechanisms as in the" exact="adult" post="SGZ of the dentate gyrus is uncertainâ€&quot;even though HIV"/>
  <result pre="genesis of neurons and glia during maturation or in the" exact="adult" post="directly via convergent pathways (Hauser and Knapp 2018; Kibaly"/>
  <result pre="et al. 2012). In human neural progenitor cells (hNPCs), sustained" exact="infection" post="with R5-tropic HIVBaL increased the proliferation and premature differentiation"/>
  <result pre="2017), were able to significantly attenuate the consequences of R5-tropic" exact="HIV infection" post="on hNPC differentiation and fate confirming a direct role"/>
  <result pre="were able to significantly attenuate the consequences of R5-tropic HIV" exact="infection" post="on hNPC differentiation and fate confirming a direct role"/>
  <result pre="Opioid and HIV Comorbidity The interplay of complex host and" exact="viral" post="genetic differences is likely to play a huge role"/>
  <result pre="among HIV-1 variants have a significant impact on HIV transmission," exact="disease" post="progression, as well as the response to ARV therapy"/>
  <result pre="more severe memory deficits, as well as greater astrogliosis and" exact="neuronal" post="damage (Rao et al. 2008, 2013). In another example,"/>
  <result pre="Chatterjee 2015). Clade B Tat is more intrinsically cytotoxic to" exact="primary" post="neurons in vitro than clade C Tat (Li et"/>
  <result pre="production (e.g., IL-6 and TNF-Î±) (Gandhi et al. 2009) and" exact="monocyte" post="recruitment/migration into the brain (Ranga et al. 2004; Rao"/>
  <result pre="TNF-Î±) (Gandhi et al. 2009) and monocyte recruitment/migration into the" exact="brain" post="(Ranga et al. 2004; Rao et al. 2008), and"/>
  <result pre="overall toxicity in MSNs seen with clade C Tat (30%" exact="neuronal" post="losses)â€‰was considerably less than with clade B (70% losses)"/>
  <result pre="al. 2012; Balinang et al. 2017; Kim et al. 2018)." exact="Increased" post="infectivity in the presence of morphine was noted for"/>
  <result pre="Host genetic variability can be a major determinant in individual" exact="susceptibility to" post="HIV infectivity and may influence neuroHIV progression in the"/>
  <result pre="homozygous in the CCR5 gene (CCR5Î&quot;32) are highly resistant to" exact="infection" post="by CCR5- (R5-) tropic HIV as demonstrated by individuals"/>
  <result pre="HIV as demonstrated by individuals heterozygous for CCR5Î&quot;32 who display" exact="partial" post="resistance to infection and slower disease progression (Huang et"/>
  <result pre="by individuals heterozygous for CCR5Î&quot;32 who display partial resistance to" exact="infection" post="and slower disease progression (Huang et al. 1996; Liu"/>
  <result pre="for CCR5Î&quot;32 who display partial resistance to infection and slower" exact="disease" post="progression (Huang et al. 1996; Liu et al. 1996;"/>
  <result pre="reviews on other gene polymorphisms that modify HIV infectivity and" exact="disease" post="progression have been published (Lama and Planelles 2007; Singh"/>
  <result pre="DRD2) drug/neurotransmitter receptor genes are associated with altered HIV infectivity," exact="viral" post="loads and CD4+ cell counts (Proudnikov et al. 2012;"/>
  <result pre="and Balogh 2012; Koob and Volkow 2016) can also affect" exact="drug dependence." post="The A118G variant of OPRM1 alters the regulation of"/>
  <result pre="regulation of proinflammatory cytokine secretion (i.e., TNF-Î±, IL-10, IFN-Î³) from" exact="peripheral" post="immune cells (Matsunaga et al. 2009). Overall, these findings"/>
  <result pre="Lu et al. 2015). OPRM1 alternative splicing may also influence" exact="susceptibility to" post="HIV-1 infection (Dever et al. 2012, 2014). Although many"/>
  <result pre="2015). OPRM1 alternative splicing may also influence susceptibility to HIV-1" exact="infection" post="(Dever et al. 2012, 2014). Although many variants are"/>
  <result pre="2012) and has been shown to correlate with HIVE and" exact="cognitive impairment" post="(Dever et al. 2012, 2014). MOR and Chemokine Receptor"/>
  <result pre="Receptor Interactions (CCR5, CXCR4) The ability of opiates to modulate" exact="HIV infection" post="and HIV neuropathogenesis/disease progression may be partly due to"/>
  <result pre="Interactions (CCR5, CXCR4) The ability of opiates to modulate HIV" exact="infection" post="and HIV neuropathogenesis/disease progression may be partly due to"/>
  <result pre="ligand, exposure with enhanced replication of both X4- and R5-tropic" exact="viral" post="strains of HIV (Steele et al. 2003). For CXCR4,"/>
  <result pre="both the MOR and CCR5 receptors simultaneously. To monitor HIV-1" exact="infection" post="(d) astrocytes and (e) microglia were transfected with a"/>
  <result pre="the loss of CCR5 from glia (but not neurons) eliminated" exact="neurotoxicity" post="due to Tat and morphine interactions (Kim et al."/>
  <result pre="al. 2018). Similarly, short-duration (5 d) maraviroc pre-treatment also eliminated" exact="neurotoxicity" post="and attenuated neuronal increases in [Ca2+]i caused by Tatâ€‰Â±â€‰morphine"/>
  <result pre="short-duration (5 d) maraviroc pre-treatment also eliminated neurotoxicity and attenuated" exact="neuronal" post="increases in [Ca2+]i caused by Tatâ€‰Â±â€‰morphine (Kim et al."/>
  <result pre="c). Naloxone or morphine by themselves had no effect on" exact="neuronal" post="survival (c). In co-cultures with CCR5-deficit glia and wild-type"/>
  <result pre="to CCR5-null glia at 24Â h (lower row;g), suggesting reduced" exact="neuronal" post="support. Although morphine significantly decreased pro-BDNF in CCR5-deficient glia"/>
  <result pre="levels (not shown), the pro-BDNF/mBDNF ratios were unaltered (upper and" exact="lower" post="rows;g). By contrast, combined Tat and morphine significantly decreased"/>
  <result pre="morphine significantly decreased the pro-BDNF/mBDNF ratio at 6Â h, suggesting" exact="transient" post="protection with CCR5 deficiency that was not fully sustained"/>
  <result pre="pro-BDNF/mBDNF ratio at 6Â h, suggesting transient protection with CCR5" exact="deficiency" post="that was not fully sustained at 24Â h (pÂ"/>
  <result pre="in mediating HIV-1 and opiate neurotoxic interactions, (2) that CCR5" exact="deficiency" post="influences signaling through MOR, and (3) that CCR5 (and"/>
  <result pre="MOR) act via a BDNF intermediary to promote or obstruct" exact="neuronal" post="survival (Kim et al. 2018). (a-b) Modified and reprinted"/>
  <result pre="been found to mimic the pro-survival effect of glial CCR5" exact="deficiency" post="against Tatâ€‰Â±â€‰morphine, and its neuroprotective effects have been supported"/>
  <result pre="and its neuroprotective effects have been supported in other neurodegenerative" exact="disease" post="models (Cai et al. 2014; Xu et al. 2018)."/>
  <result pre="function in response to inflammatory processes in the presence of" exact="HIV infection" post="(Yuferov et al. 2014). The upregulation of mRNA coding"/>
  <result pre="in response to inflammatory processes in the presence of HIV" exact="infection" post="(Yuferov et al. 2014). The upregulation of mRNA coding"/>
  <result pre="consider the potential influence of leukocyte-derived endogenous opioid peptides in" exact="neuroinflammation" post="(Rittner et al. 2001). Granulocytes express about 10-fold higher"/>
  <result pre="about 10-fold higher levels of Î²-endorphin, a preferential MOR and" exact="lower" post="affinity KOR endogenous ligand, than lymphocytes (Pallinger and Csaba"/>
  <result pre="lymphocytes (Pallinger and Csaba 2008). Increases in Î²-endorphin expression by" exact="peripheral" post="blood mononuclear cells (PBMCs) (Gironi et al. 2000; Gironi"/>
  <result pre="Gironi et al. 2003), coincide with inflammation and relapse in" exact="multiple sclerosis." post="Moreover, increases in inflammatory cytokines, such as interleukin-1Î² (IL-1Î²),"/>
  <result pre="demonstrated to differentially increase the expression of proenkephalin transcripts in" exact="primary" post="astrocytes cultured from different brain regions (Ruzicka and Akil"/>
  <result pre="expression of proenkephalin transcripts in primary astrocytes cultured from different" exact="brain" post="regions (Ruzicka and Akil 1997) and increase IL-10-stimulated Î²-endorphin"/>
  <result pre="and Akil 1997) and increase IL-10-stimulated Î²-endorphin expression in cultured" exact="primary" post="microglia (Wu et al. 2017). Interestingly, OPRM1 mRNA levels"/>
  <result pre="HIVâˆ’ subjects (Yuferov et al. 2014). PENK was downregulated in" exact="brain" post="samples from 446 PWH compared to 67 HIV negative"/>
  <result pre="and PENK mRNA levels in the hippocampus were affected by" exact="chronic" post="(but not acute) Tat exposure (Fitting et al. 2010b)."/>
  <result pre="(Kreek 1973; Kreek et al. 2002; George et al. 2012)." exact="Acute" post="opiate exposure typically activates the HPA axis, corticotropin releasing"/>
  <result pre="exposure typically activates the HPA axis, corticotropin releasing factor, and" exact="peripheral" post="steroidogenesis in a species-dependent manner (Koob and Kreek 2007;"/>
  <result pre="manner (Koob and Kreek 2007; Cleck and Blendy 2008). Alternatively," exact="chronic" post="self-administration of short-acting opiates suppresses diurnal cortisol rhythmicity (Facchinetti"/>
  <result pre="the HPA axis (Kreek 1973). Further, it is known that" exact="HIV infection" post="significantly alters the HPA axis, due to CNS toxicity"/>
  <result pre="HPA axis (Kreek 1973). Further, it is known that HIV" exact="infection" post="significantly alters the HPA axis, due to CNS toxicity"/>
  <result pre="et al. 1982, 1984). The disruptions were noticed specifically in" exact="brain" post="regions involved in reinforcement processes, including the NAc, frontal"/>
  <result pre="dopamine biosynthesis in response to excessive dopaminergic stimulation resulting from" exact="chronic" post="opiate exposure (Kish et al. 2001). Additionally, HIV is"/>
  <result pre="et al. 2000b; Gaskill et al. 2017) causing reductions in" exact="presynaptic" post="dopamine terminals and dopamine transport in the striatum (Wang"/>
  <result pre="al. 2012, 2015). The decline in dopamine function may exacerbate" exact="opioid abuse" post="tendencies and drug-seeking behaviors as the rewarding effects of"/>
  <result pre="the uptake and retention on ARV, medication adherence rates, and" exact="viral" post="suppression (Low et al. 2016; Mukandavire et al. 2017)."/>
  <result pre="include methadone, a MOR full agonist, and buprenorphine, a MOR" exact="partial" post="agonist and partial antagonist of KOR (Noble and Marie"/>
  <result pre="MOR full agonist, and buprenorphine, a MOR partial agonist and" exact="partial" post="antagonist of KOR (Noble and Marie 2018). In comparison"/>
  <result pre="and causes less opioid withdrawal symptoms potentially due to its" exact="partial" post="agonism on MOR, but also due to its high"/>
  <result pre="2014b; Carvallo et al. 2015; Dutta and Roy 2015). In" exact="primary" post="astrocytes, agonist-selective actions at MOR and KOR can be"/>
  <result pre="oxycodone, buprenorphine, and DAMGO can decrease inflammatory function and decrease" exact="monocyte" post="migration (Boland et al. 2014; Carvallo et al. 2015;"/>
  <result pre="several known drug-drug interactions between opioids and ARVs that affect" exact="systemic" post="concentrations. The partial opioid agonist, buprenorphine, is metabolized primarily"/>
  <result pre="interactions between opioids and ARVs that affect systemic concentrations. The" exact="partial" post="opioid agonist, buprenorphine, is metabolized primarily by cytochrome P450"/>
  <result pre="CYP 3A4 and UGT 1A1, leading to increases in overall" exact="systemic" post="exposure of buprenorphine and norbuprenorphine and also results in"/>
  <result pre="contrast, efavirenz and nevirapine induce CYP 3A4, resulting in decreased" exact="systemic" post="concentrations of methadone and the development of opioid withdrawal"/>
  <result pre="et al. 2017). The pharmacokinetic studies above focused on overall" exact="systemic" post="exposure of drugs. Plasma concentrations, however, are not always"/>
  <result pre="the CSF. However, CSF drug levels may not accurately predict" exact="brain" post="concentrations. For many drugs with high efflux activities (e.g.,"/>
  <result pre="efflux activities (e.g., substrates of P-gp), CSF tends to over-predict" exact="brain" post="tissue concentrations (Liu et al. 2006; Friden et al."/>
  <result pre="the ARV drug amprenavir, concentrations of [14C]-amprenavir in CSF versus" exact="brain" post="were 23.3â€‰Â±â€‰11.2 and 3.33â€‰Â±â€‰0.6 nCi/g, respectively, demonstrating overprediction of"/>
  <result pre="brain were 23.3â€‰Â±â€‰11.2 and 3.33â€‰Â±â€‰0.6 nCi/g, respectively, demonstrating overprediction of" exact="brain" post="concentrations by CSF (Polli et al. 1999). These studies"/>
  <result pre="1999). These studies illustrate the high likelihood of misinterpreting drug" exact="brain" post="penetration when using CSF as the surrogate marker. Therefore,"/>
  <result pre="using CSF as the surrogate marker. Therefore, direct measurement of" exact="brain" post="tissue concentrations in animal models are likely to be"/>
  <result pre="interactive effects of ARVs and opioids on ARV and/or opioid" exact="brain" post="exposure. A few studies have investigated the impact of"/>
  <result pre="impact of 5 d continuous exposure to morphine on ARV" exact="brain" post="concentrations (dolutegravir, lamivudine and abacavir) and demonstrated that morphine"/>
  <result pre="(Leibrand et al. 2019). Morphine alterations in P-gp within the" exact="brain" post="could have wide reaching impact on other CNS active"/>
  <result pre="and non-nucleoside reverse transcriptase inhibitors (NNRTIs) are efficacious in inhibiting" exact="viral" post="replication within monocyte-derived macrophages, only a few drugs within"/>
  <result pre="a few drugs within each ARV class can effectively inhibit" exact="viral" post="replication within astrocytes (Gray et al. 2013), which could"/>
  <result pre="demonstrated darunavir and raltegravir intracellular concentrations to be approximately 100-fold" exact="lower" post="(with higher EC50 values) in microglia than in PBMCs"/>
  <result pre="study measured intracellular concentrations of dolutegravir, tenofovir and emtricitabine in" exact="primary" post="human astrocytes, microglia, pericytes and BMECs (Patel et al."/>
  <result pre="were typically significantly higher in BMECs than in the other" exact="brain" post="cell types. Dolutegravir achieved the highest relative concentrations within"/>
  <result pre="that morphine exposure increases the proportion of cells with high" exact="susceptibility to" post="SIV infection, at least in part, because of increased"/>
  <result pre="al. 2016). In addition to promoting a higher steady state" exact="viral" post="loads and larger CD4 count declines, the model also"/>
  <result pre="of opioid agonist treatment halves the risk of HIV-1 RNA" exact="viral" post="load rebound through improved ART adherence for HIV-infected women"/>
  <result pre="Depend202020610767031711873 AdlerMWGellerEBRogersTJHendersonEEEisensteinTKOpioids, receptors, and immunityAdv Exp Med Biol199333513208237587 AlaeeAZarghamiMFarniaSKhademlooMKhoddadTComparison of" exact="brain" post="white matter hyperintensities in methamphetamine and methadone dependent patients"/>
  <result pre="and methadone dependent patients and healthy controlsIran J Radiol201411e1427525035700 AlbrightAVStrizkiJHarouseJMLaviEO'ConnorMGonzalez-ScaranoFHIV-1" exact="infection" post="of cultured human adult oligodendrocytesVirology19962172112198599205 Alexander GC, Stoller KB,"/>
  <result pre="and healthy controlsIran J Radiol201411e1427525035700 AlbrightAVStrizkiJHarouseJMLaviEO'ConnorMGonzalez-ScaranoFHIV-1 infection of cultured human" exact="adult" post="oligodendrocytesVirology19962172112198599205 Alexander GC, Stoller KB, Haffajee RL, Saloner B"/>
  <result pre="B (2020) An epidemic in the midst of a pandemic:" exact="opioid use disorder" post="and COVID-19. Ann Intern Med 173:57â€&quot;58 Al-Harthi L, Joseph"/>
  <result pre="(2020) An epidemic in the midst of a pandemic: opioid" exact="use disorder" post="and COVID-19. Ann Intern Med 173:57â€&quot;58 Al-Harthi L, Joseph"/>
  <result pre="protein alters tight junction protein expression and distribution in cultured" exact="brain" post="endothelial cells. J Neurosci Res 74:255â€&quot;265 AnthonyICRamageSNCarnieFWSimmondsPBellJEDoes drug abuse"/>
  <result pre="in cultured brain endothelial cells. J Neurosci Res 74:255â€&quot;265 AnthonyICRamageSNCarnieFWSimmondsPBellJEDoes" exact="drug abuse" post="alter microglial phenotype and cell turnover in the context"/>
  <result pre="AnthonyICNorrbyKEDingwallTCarnieFWMillarTArangoJCRobertsonRBellJEPredisposition to accelerated Alzheimer-related changes in the brains of human" exact="immunodeficiency" post="virus negative opiate abusersBrain20101333685369821126996 AouizeratBEPearceCLMiaskowskiCThe search for host genetic"/>
  <result pre="negative opiate abusersBrain20101333685369821126996 AouizeratBEPearceCLMiaskowskiCThe search for host genetic factors of" exact="HIV/AIDS" post="pathogenesis in the post-genome era: progress to date and"/>
  <result pre="post-genome era: progress to date and new avenues for discoveryCurr" exact="HIV/AIDS" post="Rep20118384421221856 ApplebaumAJReillyLCGonzalezJSRichardsonMALeveroniCLSafrenSAThe impact of neuropsychological functioning on adherence to"/>
  <result pre="impact of neuropsychological functioning on adherence to HAART in HIV-infected" exact="substance abuse" post="patientsAIDS Patient Care STDs20092345546219519229 ApplebaumAJOttoMWRichardsonMASafrenSAContributors to neuropsychological impairment in"/>
  <result pre="in HIV-infected and HIV-uninfected opiate-dependent patientsJ Clin Exp Neuropsychol20103257958919890760 AquilanteCLLetrentSPPollackGMBrouwerKLIncreased" exact="brain" post="P-glycoprotein in morphine tolerant ratsLife Sci200066PL47PL5110665989 ArnattCKFallsBAYuanYRaborgTJMasvekarRREl-HageNSelleyDENicolaAVKnappPEHauserKFZhangYExploration of bivalent"/>
  <result pre="antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to" exact="viral" post="persistence in brainRetrovirology2017144729037245 AtwoodWJTornatoreCSMeyersKMajorEOHIV-1 mRNA transcripts from persistently infected"/>
  <result pre="decreases the levels of neurotrophins in human lymphocytesAIDS2011251126112821422985 BabaMOishiRSaekiKEnhancement of" exact="blood-brain barrier" post="permeability to sodium fluorescein by stimulation of mu opioid"/>
  <result pre="of mu opioid receptors in miceNaunyn Schmiedeberg's Arch Pharmacol19883374234282841613 BachisAAvdoshinaVZeccaLParsadanianMMocchettiIHuman" exact="immunodeficiency" post="virus type 1 alters brain-derived neurotrophic factor processing in"/>
  <result pre="opioid receptors in miceNaunyn Schmiedeberg's Arch Pharmacol19883374234282841613 BachisAAvdoshinaVZeccaLParsadanianMMocchettiIHuman immunodeficiency virus" exact="type 1" post="alters brain-derived neurotrophic factor processing in neuronsJ Neurosci2012329477948422787033 BalinangJMMasvekarRRHauserKFKnappPEProductive"/>
  <result pre="1 alters brain-derived neurotrophic factor processing in neuronsJ Neurosci2012329477948422787033 BalinangJMMasvekarRRHauserKFKnappPEProductive" exact="infection" post="of human neural progenitor cells by R5 tropic HIV-1:"/>
  <result pre="Nonnemacher MR (2011) Role of mu-opioids as cofactors in human" exact="immunodeficiency" post="virus type 1 disease progression and neuropathogenesis. J Neurovirol"/>
  <result pre="(2011) Role of mu-opioids as cofactors in human immunodeficiency virus" exact="type 1" post="disease progression and neuropathogenesis. J Neurovirol 17:291â€&quot;302 BaratCProustADeshiereALeboeufMDrouinJTremblayMJAstrocytes sustain"/>
  <result pre="of mu-opioids as cofactors in human immunodeficiency virus type 1" exact="disease" post="progression and neuropathogenesis. J Neurovirol 17:291â€&quot;302 BaratCProustADeshiereALeboeufMDrouinJTremblayMJAstrocytes sustain long-term"/>
  <result pre="and neuropathogenesis. J Neurovirol 17:291â€&quot;302 BaratCProustADeshiereALeboeufMDrouinJTremblayMJAstrocytes sustain long-term productive HIV-1" exact="infection" post="without establishment of reactivable viral latencyGlia2018661363138129464785 Barbour AJ, Hauser"/>
  <result pre="BaratCProustADeshiereALeboeufMDrouinJTremblayMJAstrocytes sustain long-term productive HIV-1 infection without establishment of reactivable" exact="viral" post="latencyGlia2018661363138129464785 Barbour AJ, Hauser KF, McQuiston AR, Knapp PE"/>
  <result pre="dysregulate K+-Cl cotransporter 2 (KCC2) to cause GABAergic dysfunction in" exact="primary" post="human neurons and Tat-transgenic mice. Neurobiol Dis 141: 104878"/>
  <result pre="neurons and Tat-transgenic mice. Neurobiol Dis 141: 104878 BauerLOEffects of" exact="chronic" post="opioid dependence and HIV-1 infection on pattern shift visual"/>
  <result pre="Dis 141: 104878 BauerLOEffects of chronic opioid dependence and HIV-1" exact="infection" post="on pattern shift visual evoked potentialsDrug Alcohol Depend1998501471559649966 Becker"/>
  <result pre="of chronic opioid dependence and HIV-1 infection on pattern shift" exact="visual" post="evoked potentialsDrug Alcohol Depend1998501471559649966 Becker WC, Fiellin DA (2020)"/>
  <result pre="Depend1998501471559649966 Becker WC, Fiellin DA (2020) When epidemics collide: coronavirus" exact="disease" post="2019 (COVID-19) and the opioid crisis. Ann Intern Med"/>
  <result pre="and the opioid crisis. Ann Intern Med 173: 59-60 BednarMMSturdevantCBTompkinsLAArrildtKTDukhovlinovaEKincerLPSwanstromRCompartmentalization," exact="viral" post="evolution, and viral latency of HIV in the CNSCurr"/>
  <result pre="crisis. Ann Intern Med 173: 59-60 BednarMMSturdevantCBTompkinsLAArrildtKTDukhovlinovaEKincerLPSwanstromRCompartmentalization, viral evolution, and" exact="viral" post="latency of HIV in the CNSCurr HIV/AIDS Rep20151226227125914150 Belcheva"/>
  <result pre="viral evolution, and viral latency of HIV in the CNSCurr" exact="HIV/AIDS" post="Rep20151226227125914150 Belcheva MM, Tan Y, Heaton VM, Clark AL,"/>
  <result pre="of opioid use disorderBiol Psychiatry202087828831420089 BellJEBrettleRPChiswickASimmondsPHIV encephalitis, proviral load and" exact="dementia" post="in drug users and homosexuals with AIDS. Effect of"/>
  <result pre="Acquir Immune Defic Syndr200231Suppl 2S35S4212394781 BellJEArangoJCAnthonyICNeurobiology of multiple insults: HIV-1-associated" exact="brain" post="disorders in those who use illicit drugsJ NeuroImmune Pharmacol2006118219118040783"/>
  <result pre="drug that causes reduced tolerance and dependenceAnn Neurol20106755956920437553 BermanJWet al.NeuroAIDS," exact="drug abuse," post="and inflammation: building collaborative research activitiesJ NeuroImmune Pharmacol2006135139918040811 BernardoAAgrestiCLeviGHIV-gp120"/>
  <result pre="Pharmacol2006135139918040811 BernardoAAgrestiCLeviGHIV-gp120 affects the functional activity of oligodendrocytes and their" exact="susceptibility to" post="complementJ Neurosci Res1997509469579452009 BlanksonJNPersaudDSilicianoRFThe challenge of viral reservoirs in"/>
  <result pre="and their susceptibility to complementJ Neurosci Res1997509469579452009 BlanksonJNPersaudDSilicianoRFThe challenge of" exact="viral" post="reservoirs in HIV-1 infectionAnnu Rev Med20025355759311818490 BodnarRJEndogenous opiates and"/>
  <result pre="Îº-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6" exact="glioma" post="cells. J Neurochem 74:574â€&quot;581 Boivin MJ, Ruel TD, Boal"/>
  <result pre="murine microglia. J Neurovirol 15:219â€&quot;228 BokhariSMHegdeRCallenSYaoHAdanyILiQLiZPinsonDYehHWCheneyPDBuchSMorphine potentiates neuropathogenesis of SIV" exact="infection" post="in rhesus macaquesJ NeuroImmune Pharmacol2011662663921431470 BolandJWFouldsGAAhmedzaiSHPockleyAGA preliminary evaluation of"/>
  <result pre="95:9608â€&quot;9613 BoraEYucelMFornitoAPantelisCHarrisonBJCocchiLPellGLubmanDIWhite matter microstructure in opiate addictionAddict Biol20121714114821070508 BoskaMDDashPKKnibbeJEpsteinAAAkhterSPFieldsNHighRMakarovEBonaseraSGelbardHAPoluektovaLYGendelmanHEGorantlaSAssociations between" exact="brain" post="microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection"/>
  <result pre="Biol20121714114821070508 BoskaMDDashPKKnibbeJEpsteinAAAkhterSPFieldsNHighRMakarovEBonaseraSGelbardHAPoluektovaLYGendelmanHEGorantlaSAssociations between brain microstructures, metabolites, and cognitive deficits during" exact="chronic" post="HIV-1 infection of humanized miceMol Neurodegener201495825523827 BourneRSMillsGHSleep disruption in"/>
  <result pre="between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1" exact="infection" post="of humanized miceMol Neurodegener201495825523827 BourneRSMillsGHSleep disruption in critically ill"/>
  <result pre="Infect Dis200643Suppl 4S216S22317109308 BruehlSApkarianAVBallantyneJCBergerABorsookDChenWGFarrarJTHaythornthwaiteJAHornSDIadarolaMJInturrisiCELaoLMackeySMaoJSawczukAUhlGRWitterJWoolfCJZubietaJKLinYPersonalized medicine and opioid analgesic prescribing for" exact="chronic" post="pain: opportunities and challengesThe journal of pain : official"/>
  <result pre="and challengesThe journal of pain : official journal of the" exact="American" post="Pain Society20131410311323374939 BrunerKMet al.A quantitative approach for measuring the"/>
  <result pre="patterns of expression of opioid receptors and relationship to human" exact="immunodeficiency" post="virus-1 Tat and morphine susceptibility in vitro. Neuroscience 146:1546â€&quot;1554"/>
  <result pre="in drug abusers : the involvement of neurons, glial, and" exact="vascular" post="systemsForensic Sci Med Pathol2006211512625868590 Buttner A, Rohrmoser K, Mall"/>
  <result pre="Rohrmoser K, Mall G, Penning R, Weis S (2006) Widespread" exact="axonal" post="damage in the brain of drug abusers as evidenced"/>
  <result pre="Penning R, Weis S (2006) Widespread axonal damage in the" exact="brain" post="of drug abusers as evidenced by accumulation of Î²-amyloid"/>
  <result pre="Safdieh G, Morgello S (2012) Impact of opiate addiction on" exact="neuroinflammation" post="in HIV. J Neurovirol 18:364â€&quot;373 CadetJLBisagnoVMilroyCMNeuropathology of substance use"/>
  <result pre="substance use disordersActa Neuropathol20141279110724292887 CaiJHuaFYuanLTangWLuJYuSWangXHuYPotential therapeutic effects of neurotrophins for" exact="acute" post="and chronic neurological diseasesBiomed Res Int2014201460108424818146 Campbell GR, Watkins"/>
  <result pre="disordersActa Neuropathol20141279110724292887 CaiJHuaFYuanLTangWLuJYuSWangXHuYPotential therapeutic effects of neurotrophins for acute and" exact="chronic" post="neurological diseasesBiomed Res Int2014201460108424818146 Campbell GR, Watkins JD, Loret"/>
  <result pre="JD, Loret EP, Spector SA (2011) Differential induction of rat" exact="neuronal" post="excitotoxic cell death by human immunodeficiency virus type 1"/>
  <result pre="Differential induction of rat neuronal excitotoxic cell death by human" exact="immunodeficiency" post="virus type 1 clade B and C Tat proteins."/>
  <result pre="of rat neuronal excitotoxic cell death by human immunodeficiency virus" exact="type 1" post="clade B and C Tat proteins. AIDS Res Hum"/>
  <result pre="and C Tat proteins. AIDS Res Hum Retrovir 27:647â€&quot;654 Canto-NoguesCSanchez-RamonSAlvarezSLacruzCMunoz-FernandezMAHIV-1" exact="infection" post="of neurons might account for progressive HIV-1-associated encephalopathy in"/>
  <result pre="27:647â€&quot;654 Canto-NoguesCSanchez-RamonSAlvarezSLacruzCMunoz-FernandezMAHIV-1 infection of neurons might account for progressive HIV-1-associated" exact="encephalopathy" post="in childrenJ Mol Neurosci200527798916055948 Caputi FF, Rullo L, Stamatakos"/>
  <result pre="of monocytesJ Immunol20151943246325825716997 CDC (2017) Understanding the epidemic. Centers for" exact="Disease" post="Control and Prevention, National Center for Injury Prevention and"/>
  <result pre="https://www.cdc.gov/drugoverdose/epidemic/index.html ChangSLBeltranJASwarupSExpression of the mu opioid receptor in the human" exact="immunodeficiency" post="virus type 1 transgenic rat modelJ Virol2007818406841117553897 ChangLWangGJVolkowNDErnstTTelangFLoganJFowlerJSDecreased brain"/>
  <result pre="of the mu opioid receptor in the human immunodeficiency virus" exact="type 1" post="transgenic rat modelJ Virol2007818406841117553897 ChangLWangGJVolkowNDErnstTTelangFLoganJFowlerJSDecreased brain dopamine transporters are"/>
  <result pre="human immunodeficiency virus type 1 transgenic rat modelJ Virol2007818406841117553897 ChangLWangGJVolkowNDErnstTTelangFLoganJFowlerJSDecreased" exact="brain" post="dopamine transporters are related to cognitive deficits in HIV"/>
  <result pre="Med Biol199640229338787640 ChaoCCGekkerGHuSShengWSSharkKBBuDFArcherSBidlackJMPetersonPKÎº opioid receptors in human microglia downregulate human" exact="immunodeficiency" post="virus 1 expressionProc Natl Acad Sci U S A199693805180568755601"/>
  <result pre="Hu S, Kravitz F, Peterson PK (1998a) Îº-Opioid potentiation of" exact="tumor" post="necrosis factor-Î±-induced anti-HIV-1 activity in acutely infected human brain"/>
  <result pre="of tumor necrosis factor-Î±-induced anti-HIV-1 activity in acutely infected human" exact="brain" post="cell cultures. Biochem Pharmacol 56:397â€&quot;404 ChaoCCGekkerGShengWSHuSLohHHPetersonPKOrphan opioid receptor oligonucleotides"/>
  <result pre="56:397â€&quot;404 ChaoCCGekkerGShengWSHuSLohHHPetersonPKOrphan opioid receptor oligonucleotides inhibit HIV-1 expression in human" exact="brain" post="cellsAdv Exp Med Biol199843783909666260 ChaoCCHuSGekkerGLokensgardJRHeyesMPPetersonPKU50,488 protection against HIV-1-related neurotoxicity:"/>
  <result pre="of GSK-3Î²/Î²-catenin. J NeuroImmune Pharmacol 9:259â€&quot;268 ChatterjeeKHost genetic factors in" exact="susceptibility to" post="HIV-1 infection and progression to AIDSJ Genet20108910911620505255 ChavesCGomez-ZepedaDAuvitySMenetMCCreteDLabatLRemiaoFCisterninoSDeclevesXEffect of"/>
  <result pre="NeuroImmune Pharmacol 9:259â€&quot;268 ChatterjeeKHost genetic factors in susceptibility to HIV-1" exact="infection" post="and progression to AIDSJ Genet20108910911620505255 ChavesCGomez-ZepedaDAuvitySMenetMCCreteDLabatLRemiaoFCisterninoSDeclevesXEffect of subchronic intravenous"/>
  <result pre="factors in cultured astrocytes. PLoS One 15:e0230563 ChilundaVCalderonTMMartinez-AguadoPBermanJWThe impact of" exact="substance abuse" post="on HIV-mediated neuropathogenesis in the current ART eraBrain Res2019172414642631473221"/>
  <result pre="the current ART eraBrain Res2019172414642631473221 ChoiSYerneniRHealySGoyalMNeighborsCJPredictors of medication utilization for" exact="opioid use disorder" post="among medicaid-insured HIV patients in New YorkThe American journal"/>
  <result pre="current ART eraBrain Res2019172414642631473221 ChoiSYerneniRHealySGoyalMNeighborsCJPredictors of medication utilization for opioid" exact="use disorder" post="among medicaid-insured HIV patients in New YorkThe American journal"/>
  <result pre="opioid use disorder among medicaid-insured HIV patients in New YorkThe" exact="American" post="journal on addictions / American Academy of Psychiatrists in"/>
  <result pre="HIV patients in New YorkThe American journal on addictions /" exact="American" post="Academy of Psychiatrists in Alcoholism and Addictions202029151154 ChrousosGPZapantiEDHypothalamic-pituitary-adrenal axis"/>
  <result pre="Academy of Psychiatrists in Alcoholism and Addictions202029151154 ChrousosGPZapantiEDHypothalamic-pituitary-adrenal axis in" exact="HIV infection" post="and diseaseEndocrinol Metab Clin N Am201443791806 ChurchillMJGorryPRCowleyDLalLSonzaSPurcellDFThompsonKAGabuzdaDMcArthurJCPardoCAWesselinghSLUse of laser"/>
  <result pre="of Psychiatrists in Alcoholism and Addictions202029151154 ChrousosGPZapantiEDHypothalamic-pituitary-adrenal axis in HIV" exact="infection" post="and diseaseEndocrinol Metab Clin N Am201443791806 ChurchillMJGorryPRCowleyDLalLSonzaSPurcellDFThompsonKAGabuzdaDMcArthurJCPardoCAWesselinghSLUse of laser"/>
  <result pre="detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy" exact="brain" post="tissuesJ Neuro-Oncol200612146152 ChurchillMJWesselinghSLCowleyDPardoCAMcArthurJCBrewBJGorryPRExtensive astrocyte infection is prominent in human"/>
  <result pre="macrophages and astrocytes from autopsy brain tissuesJ Neuro-Oncol200612146152 ChurchillMJWesselinghSLCowleyDPardoCAMcArthurJCBrewBJGorryPRExtensive astrocyte" exact="infection" post="is prominent in human immunodeficiency virus-associated dementiaAnn Neurol20096625325819743454 ChurchillMJDeeksSGMargolisDMSilicianoRFSwanstromRHIV"/>
  <result pre="brain tissuesJ Neuro-Oncol200612146152 ChurchillMJWesselinghSLCowleyDPardoCAMcArthurJCBrewBJGorryPRExtensive astrocyte infection is prominent in human" exact="immunodeficiency" post="virus-associated dementiaAnn Neurol20096625325819743454 ChurchillMJDeeksSGMargolisDMSilicianoRFSwanstromRHIV reservoirs: what, where and how"/>
  <result pre="to target themNat Rev Microbiol201614556026616417 ClarkeSMMulcahyFMTjiaJReynoldsHEGibbonsSEBarryMGBackDJThe pharmacokinetics of methadone in" exact="HIV-positive" post="patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenzBr J"/>
  <result pre="stress on drug addictionJ Clin Invest200811845446118246196 CloakCCChangLO'NeilSPErnstTMAndersonDCDonahoeRMNeurometabolite abnormalities in simian" exact="immunodeficiency" post="virus-infected macaques with chronic morphine administrationJ NeuroImmune Pharmacol2011637138020938808 CollerJKHutchinsonMRImplications"/>
  <result pre="Clin Invest200811845446118246196 CloakCCChangLO'NeilSPErnstTMAndersonDCDonahoeRMNeurometabolite abnormalities in simian immunodeficiency virus-infected macaques with" exact="chronic" post="morphine administrationJ NeuroImmune Pharmacol2011637138020938808 CollerJKHutchinsonMRImplications of central immune signaling"/>
  <result pre="menNeuroepidemiology19971678859057169 CorreaDGZimmermannNDoringTMWilnerNVLeiteSCCabralRFFonsecaRPBahiaPRGasparettoELDiffusion tensor MR imaging of white matter integrity in" exact="HIV-positive" post="patients with planning deficitNeuroradiology20155747548225604843 CostaANappiREPolattiFPomaAGrossmanABNappiGStimulating effect of HIV-1 coat"/>
  <result pre="receptor is associated with quantitative measures of drug use in" exact="African" post="American womenAddict Biol20121718119121070507 Culpepper-MorganJAKreekMJHypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in"/>
  <result pre="is associated with quantitative measures of drug use in African" exact="American" post="womenAddict Biol20121718119121070507 Culpepper-MorganJAKreekMJHypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid"/>
  <result pre="of drug use in African American womenAddict Biol20121718119121070507 Culpepper-MorganJAKreekMJHypothalamic-pituitary-adrenal axis" exact="hypersensitivity" post="to naloxone in opioid dependence: a case of naloxone-induced"/>
  <result pre="withdrawalMetab Clin Exp1997461301349030816 DallastaLMPisarovLAEsplenJEWerleyJVMosesAVNelsonJAAchimCLBlood-brain barrier tight junction disruption in human" exact="immunodeficiency" post="virus-1 encephalitisAm J Pathol19991551915192710595922 DanosPVan RoosDKasperSBromelTBroichKKrappelCSolymosiLMollerHJEnlarged cerebrospinal fluid spaces"/>
  <result pre="stereological CT studyNeuropsychobiology19983880839732207 DaveRSMorphine affects HIV-induced inflammatory response without influencing" exact="viral" post="replication in human monocyte-derived macrophagesFEMS Immunol Med Microbiol20126422823622066570 Del"/>
  <result pre="of HIV-1 Tat and JCV capsid protein, VP1, in AIDS" exact="brain" post="with progressive multifocal leukoencephalopathy. J Neurovirol 6:221â€&quot;228 DenisCMMoralesKHWuQMetzgerDSCheatleMDAssociation between"/>
  <result pre="Tat and JCV capsid protein, VP1, in AIDS brain with" exact="progressive multifocal leukoencephalopathy." post="J Neurovirol 6:221â€&quot;228 DenisCMMoralesKHWuQMetzgerDSCheatleMDAssociation between diagnoses of chronic noncancer"/>
  <result pre="progressive multifocal leukoencephalopathy. J Neurovirol 6:221â€&quot;228 DenisCMMoralesKHWuQMetzgerDSCheatleMDAssociation between diagnoses of" exact="chronic" post="noncancer pain, substance use disorder, and HIV-related outcomes in"/>
  <result pre="J Neurovirol 6:221â€&quot;228 DenisCMMoralesKHWuQMetzgerDSCheatleMDAssociation between diagnoses of chronic noncancer pain," exact="substance use disorder," post="and HIV-related outcomes in people living with HIVJ Acquir"/>
  <result pre="Neurovirol 6:221â€&quot;228 DenisCMMoralesKHWuQMetzgerDSCheatleMDAssociation between diagnoses of chronic noncancer pain, substance" exact="use disorder," post="and HIV-related outcomes in people living with HIVJ Acquir"/>
  <result pre="and HIV-1 regulation of Î¼-opioid receptor splice variants across human" exact="central nervous system" post="cell types. J Neurovirol 18:181â€&quot;190 Dever SM, Costin BN,"/>
  <result pre="DonahoeRMFalekANeuroimmunomodulation by opiates and other drugs of abuse: relationship to" exact="HIV infection" post="and AIDSAdv Biochem Psychopharmacol1988441451583041744 DonahoeRMVlahovDOpiates as potential cofactors in"/>
  <result pre="by opiates and other drugs of abuse: relationship to HIV" exact="infection" post="and AIDSAdv Biochem Psychopharmacol1988441451583041744 DonahoeRMVlahovDOpiates as potential cofactors in"/>
  <result pre="Biochem Psychopharmacol1988441451583041744 DonahoeRMVlahovDOpiates as potential cofactors in progression of HIV-1" exact="infections" post="to AIDSJ Neuroimmunol19988377879610676 DonahoeRMFalekAMaddenJJNicholsonJKBokosPGallegosKVeitREffects of cocaine and other drugs"/>
  <result pre="role of intravenous drug useAIDS2004182210221215577659 DublinSWalkerRLGraySLHubbardRAAndersonMLYuOCranePKLarsonEBPrescription opioids and risk of" exact="dementia" post="or cognitive decline: a prospective cohort studyJ Am Geriatr"/>
  <result pre="decline: a prospective cohort studyJ Am Geriatr Soc2015631519152626289681 DuncanMJBruce-KellerAJConnerCKnappPEXuRNathAHauserKFEffects of" exact="chronic" post="expression of the HIV-induced protein, transactivator of transcription, on"/>
  <result pre="J Physiol Regul Integr Comp Physiol2008295R1680R168718784333 DuttaRRoySMechanism(s) involved in opioid" exact="drug abuse" post="modulation of HANDCurr HIV Res20121046947722591371 Dutta R, Roy S"/>
  <result pre="modulation of HANDCurr HIV Res20121046947722591371 Dutta R, Roy S (2015)" exact="Chronic" post="morphine and HIV-1 Tat promote differential central nervous system"/>
  <result pre="Roy S (2015) Chronic morphine and HIV-1 Tat promote differential" exact="central nervous system" post="trafficking of CD3+ and Ly6C+ immune cells in a"/>
  <result pre="CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae" exact="infection" post="model. J Neuroinflammation 12:120 Dutta R, Krishnan A, Meng"/>
  <result pre="Immunol Investig 40:498â€&quot;522 El-HageNDeverSMFittingSAhmedTHauserKFHIV-1 coinfection and morphine coexposure severely dysregulate" exact="hepatitis C" post="virus-induced hepatic proinflammatory cytokine release and free radical production:"/>
  <result pre="El-HageNRodriguezMPodhaizerEMZouSDeverSMSniderSEKnappPEBeardsleyPMHauserKFIbudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and" exact="neuronal" post="death induced by HIV-1 and morphineAIDS2014281409141924732776 ElkaderASprouleBBuprenorphine: clinical pharmacokinetics"/>
  <result pre="of opioid dependenceClin Pharmacokinet20054466168015966752 EnsoliFEnsoliBThieleCJHIV-1 gene expression and replication in" exact="neuronal" post="and glial cell lines with immature phenotype: effects of"/>
  <result pre="neuronal and glial cell lines with immature phenotype: effects of" exact="nerve" post="growth factorVirology19942006686768178451 EranABarakMPosterior reversible encephalopathy syndrome after combined general"/>
  <result pre="with immature phenotype: effects of nerve growth factorVirology19942006686768178451 EranABarakMPosterior reversible" exact="encephalopathy" post="syndrome after combined general and spinal anesthesia with intrathecal"/>
  <result pre="immature phenotype: effects of nerve growth factorVirology19942006686768178451 EranABarakMPosterior reversible encephalopathy" exact="syndrome" post="after combined general and spinal anesthesia with intrathecal morphineAnesth"/>
  <result pre="with intrathecal morphineAnesth Analg200910860961219151296 ErikssonPSHanssonERonnbackLDelta and kappa opiate receptors in" exact="primary" post="astroglial cultures. Part II: receptor sets in cultures from"/>
  <result pre="astroglial cultures. Part II: receptor sets in cultures from various" exact="brain" post="regions and interactions with beta-receptor activated cyclic AMPNeurochem Res1992175455511318509"/>
  <result pre="opioidsPain Manag Nurs20045759315297954 EsiriMMMorrisCSMillardPRFate of oligodendrocytes in HIV-1 infectionAIDS19915108110881657038 EugeninEAClementsJEZinkMCBermanJWHuman" exact="immunodeficiency" post="virus infection of human astrocytes disrupts blood-brain barrier integrity"/>
  <result pre="Manag Nurs20045759315297954 EsiriMMMorrisCSMillardPRFate of oligodendrocytes in HIV-1 infectionAIDS19915108110881657038 EugeninEAClementsJEZinkMCBermanJWHuman immunodeficiency" exact="virus infection" post="of human astrocytes disrupts blood-brain barrier integrity by a"/>
  <result pre="Nurs20045759315297954 EsiriMMMorrisCSMillardPRFate of oligodendrocytes in HIV-1 infectionAIDS19915108110881657038 EugeninEAClementsJEZinkMCBermanJWHuman immunodeficiency virus" exact="infection" post="of human astrocytes disrupts blood-brain barrier integrity by a"/>
  <result pre="HIV-1 infectionAIDS19915108110881657038 EugeninEAClementsJEZinkMCBermanJWHuman immunodeficiency virus infection of human astrocytes disrupts" exact="blood-brain barrier" post="integrity by a gap junction-dependent mechanismJ Neurosci2011319456946521715610 Evaluation -"/>
  <result pre="Institute for Health Metrics and Evaluation (2017) Global burden of" exact="disease" post="study. Global Health Data Exchange. http://www.healthdata.org/gbd/gbd-2017-resources. FacchinettiFGrassoAPetragliaFParriniDVolpeAGenazzaniARImpaired circadian rhythmicity"/>
  <result pre="and activation of notch signaling pathwayJ Neurosci201636113621137327807176 FanRSchrottLMArnoldTSnellingSRaoMGrahamDCorneliusAKorneevaNLChronic oxycodone induces" exact="axonal" post="degeneration in rat brainBMC Neurosci2018191529571287 FauciASRedfieldRRSigounasGWeahkeeMDGiroirBPEnding the HIV epidemic:"/>
  <result pre="S, Khalili K, Rappaport J (2001) CNS invasion by CD14+/CD16+" exact="peripheral" post="blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir"/>
  <result pre="blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of" exact="HIV infection." post="J Neurovirol 7:528â€&quot;541 Fitting S, Zou S, Chen W,"/>
  <result pre="A, Knapp PE, Hauser KF (2010b) Interactive comorbidity between opioid" exact="drug abuse" post="and HIV-1 Tat: chronic exposure augments spine loss and"/>
  <result pre="(2010b) Interactive comorbidity between opioid drug abuse and HIV-1 Tat:" exact="chronic" post="exposure augments spine loss and sublethal dendritic pathology in"/>
  <result pre="between opioid drug abuse and HIV-1 Tat: chronic exposure augments" exact="spine" post="loss and sublethal dendritic pathology in striatal neurons. Am"/>
  <result pre="Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through" exact="focal" post="disruptions in Na+ influx, mitochondrial instability, and Ca2+ overload."/>
  <result pre="using a novel data set of unbound drug concentrations in" exact="brain" post="interstitial and cerebrospinal fluidsJ Med Chem2009526233624319764786 FukagawaHKoyamaTKakuyamaMFukudaKMicroglial activation involved"/>
  <result pre="J, Rao KV, Nair MP (2009) Differential effects of HIV" exact="type 1" post="clade B and clade C Tat protein on expression"/>
  <result pre="Tat protein on expression of proinflammatory and antiinflammatory cytokines by" exact="primary" post="monocytes. AIDS Res Hum Retrovir 25:691â€&quot;699 Gaskill PJ, Miller"/>
  <result pre="P, Saxena SK, Nair MPN (2010) Interactive role of human" exact="immunodeficiency" post="virus type 1 (HIV-1) clade-specific Tat protein and cocaine"/>
  <result pre="SK, Nair MPN (2010) Interactive role of human immunodeficiency virus" exact="type 1" post="(HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier"/>
  <result pre="virus type 1 (HIV-1) clade-specific Tat protein and cocaine in" exact="blood-brain barrier" post="dysfunction: Implications for HIV-1â€&quot;associated neurocognitive disorder. J Neurovirol 16(4):294â€&quot;305"/>
  <result pre="protein and cocaine in blood-brain barrier dysfunction: Implications for HIV-1â€&quot;associated" exact="neurocognitive disorder." post="J Neurovirol 16(4):294â€&quot;305 GekkerGHuSWentlandMPBidlackJMLokensgardJRPetersonPKKappa-opioid receptor ligands inhibit cocaine-induced HIV-1"/>
  <result pre="in HIV-associated neurocognitive disorders and encephalitisJ NeuroImmune Pharmacol2012768670022391864 GeorgeMMBhangooAHuman immune" exact="deficiency" post="virus (HIV) infection and the hypothalamic pituitary adrenal axisRev"/>
  <result pre="disorders and encephalitisJ NeuroImmune Pharmacol2012768670022391864 GeorgeMMBhangooAHuman immune deficiency virus (HIV)" exact="infection" post="and the hypothalamic pituitary adrenal axisRev Endocr Metab Disord20131410511223728720"/>
  <result pre="epidemiology and significance for HIV managementCurr Opin Infect Dis2006191716374210 GinsbergMDHedley-WhyteETRichardsonEPJrHypoxic-ischemic" exact="leukoencephalopathy" post="in manArch Neurol1976335141247396 Gironi M, Martinelli V, Brambilla E,"/>
  <result pre="Panerai AE, Comi G, Sacerdote P (2000) Î²-endorphin concentrations in" exact="peripheral" post="blood mononuclear cells of patients with multiple sclerosis: effects"/>
  <result pre="concentrations in PBMC of patients with different clinical phenotypes of" exact="multiple sclerosis." post="J Neurol Neurosurg Psychiatry 74:495â€&quot;497 GnanakaranSLangDDanielsMBhattacharyaTDerdeynCAKorberBClade-specific differences between human"/>
  <result pre="sclerosis. J Neurol Neurosurg Psychiatry 74:495â€&quot;497 GnanakaranSLangDDanielsMBhattacharyaTDerdeynCAKorberBClade-specific differences between human" exact="immunodeficiency" post="virus type 1 clades B and C: diversity and"/>
  <result pre="Neurol Neurosurg Psychiatry 74:495â€&quot;497 GnanakaranSLangDDanielsMBhattacharyaTDerdeynCAKorberBClade-specific differences between human immunodeficiency virus" exact="type 1" post="clades B and C: diversity and correlations in C3-V4"/>
  <result pre="WL, Hauser KF, Paris JJ (2018) CCR5 mediates HIV-1 Tat-induced" exact="neuroinflammation" post="and influences morphine tolerance, dependence, and reward. Brain Behav"/>
  <result pre="HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward." exact="Brain" post="Behav Immun 69:124â€&quot;138 GorryPROngCThorpeJBannwarthSThompsonKAGatignolAVesselinghSLPurcellDFAstrocyte infection by HIV-1: mechanisms of"/>
  <result pre="morphine tolerance, dependence, and reward. Brain Behav Immun 69:124â€&quot;138 GorryPROngCThorpeJBannwarthSThompsonKAGatignolAVesselinghSLPurcellDFAstrocyte" exact="infection" post="by HIV-1: mechanisms of restricted virus replication, and role"/>
  <result pre="pathogenesis of HIV-1-associated dementiaCurr HIV Res2003146347315049431 GosztonyiGSchmidtVNickelRRothschildMACamachoSSiegelGZillEPauliGSchneiderVNeuropathologic analysis of postmortal" exact="brain" post="samples of HIV-seropositive and -seronegative i.v. drug addictsForensic Sci"/>
  <result pre="of HIV-seropositive and -seronegative i.v. drug addictsForensic Sci Int1993621011058300019 GosztonyiGArtigasJLamperthLWebsterHDHuman" exact="immunodeficiency" post="virus (HIV) distribution in HIV encephalitis: study of 19"/>
  <result pre="antagonismMol Pain201063320525224 GruberSASilveriMMYurgelun-ToddDANeuropsychological consequences of opiate useNeuropsychol Rev20071729931517690984 GuoC-JLiYTianSWangXDouglasSDHoW-ZMorphine enhances" exact="HIV infection" post="of human blood mononuclear phagocytes through modulation of Î²-chemokines"/>
  <result pre="Pain201063320525224 GruberSASilveriMMYurgelun-ToddDANeuropsychological consequences of opiate useNeuropsychol Rev20071729931517690984 GuoC-JLiYTianSWangXDouglasSDHoW-ZMorphine enhances HIV" exact="infection" post="of human blood mononuclear phagocytes through modulation of Î²-chemokines"/>
  <result pre="Î²-chemokines and CCR5 receptorJ Investig Med20025043544212425430 GuoMBryantJSultanaSJonesORoyalW3rdEffects of vitamin a" exact="deficiency" post="and opioids on parvalbumin + interneurons in the hippocampus"/>
  <result pre="BS, Satish KS, Kumar M (2007) Neuropsychological deficits in human" exact="immunodeficiency" post="virus type 1 clade C-seropositive adults from South India."/>
  <result pre="KS, Kumar M (2007) Neuropsychological deficits in human immunodeficiency virus" exact="type 1" post="clade C-seropositive adults from South India. J Neurovirol 13:195â€&quot;202"/>
  <result pre="Zhang J, Martin KM, Chen Y, Hauser KF (2001) Synergistic" exact="neurotoxicity" post="of opioids and human immunodeficiency virus-1 Tat protein in"/>
  <result pre="Y, Hauser KF (2001) Synergistic neurotoxicity of opioids and human" exact="immunodeficiency" post="virus-1 Tat protein in striatal neurons in vitro. Neuroscience"/>
  <result pre="AH, Hauser KF, Sim-Selley LJ, Selley DE, Knapp PE (2016)" exact="Central" post="HIV-1 Tat exposure elevates anxiety and fear conditioned responses"/>
  <result pre="Selley DE, Knapp PE (2016) Central HIV-1 Tat exposure elevates" exact="anxiety" post="and fear conditioned responses of male mice concurrent with"/>
  <result pre="with abuse liability hijack the endogenous opioid system to disrupt" exact="neuronal" post="and glial maturation in the central nervous systemFront Pediatr2018529429410949"/>
  <result pre="and astroglial development: morphine inhibits DNA synthesis and stimulates cellular" exact="hypertrophy" post="through a Ca2+ -dependent mechanism. Brain Res 720:191â€&quot;203 HauserKFEl-HageNBuchSBergerJRTyorWRNathABruce-KellerAJKnappPEMolecular"/>
  <result pre="synthesis and stimulates cellular hypertrophy through a Ca2+ -dependent mechanism." exact="Brain" post="Res 720:191â€&quot;203 HauserKFEl-HageNBuchSBergerJRTyorWRNathABruce-KellerAJKnappPEMolecular targets of opiate drug abuse in"/>
  <result pre="Ca2+ -dependent mechanism. Brain Res 720:191â€&quot;203 HauserKFEl-HageNBuchSBergerJRTyorWRNathABruce-KellerAJKnappPEMolecular targets of opiate" exact="drug abuse" post="in neuroAIDSNeurotox Res20058638016260386 HauserKFEl-HageNStiene-MartinAMaragosWFNathAPersidskyYVolskyDJKnappPEHIV-1 neuropathogenesis: glial mechanisms revealed through"/>
  <result pre="HIV Res20121043545222591368 HermanAIBaloghKNPolymorphisms of the serotonin transporter and receptor genes:" exact="susceptibility to" post="substance abuseSubst Abus Rehabil201234957 HoWZGuoCJYuanCSDouglasSDMossJMethylnaltrexone antagonizes opioid-mediated enhancement of"/>
  <result pre="to substance abuseSubst Abus Rehabil201234957 HoWZGuoCJYuanCSDouglasSDMossJMethylnaltrexone antagonizes opioid-mediated enhancement of" exact="HIV infection" post="of human blood mononuclear phagocytesJ Pharmacol Exp Ther20033071158116214560041 HuSShengWSRockRBImmunomodulatory"/>
  <result pre="substance abuseSubst Abus Rehabil201234957 HoWZGuoCJYuanCSDouglasSDMossJMethylnaltrexone antagonizes opioid-mediated enhancement of HIV" exact="infection" post="of human blood mononuclear phagocytesJ Pharmacol Exp Ther20033071158116214560041 HuSShengWSRockRBImmunomodulatory"/>
  <result pre="(2012) Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated" exact="neuronal" post="dysfunction. Cell Death Dis 3:e381 HuangYPaxtonWAWolinskySMNeumannAUZhangLHeTKangSCeradiniDJinZYazdanbakhshKKunstmanKEricksonDDragonELandauNRPhairJHoDDKoupRAThe role of a"/>
  <result pre="role of a mutant CCR5 allele in HIV-1 transmission and" exact="disease" post="progressionNat Med19962124012438898752 HutchinsonMRNorthcuttALChaoLWKearneyJJZhangYBerkelhammerDLLoramLCRozeskeRRBlandSTMaierSFGleesonTTWatkinsLRMinocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced"/>
  <result pre="in HIV-1 transmission and disease progressionNat Med19962124012438898752 HutchinsonMRNorthcuttALChaoLWKearneyJJZhangYBerkelhammerDLLoramLCRozeskeRRBlandSTMaierSFGleesonTTWatkinsLRMinocycline suppresses morphine-induced" exact="respiratory" post="depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesiaBrain"/>
  <result pre="HutchinsonMRNorthcuttALChaoLWKearneyJJZhangYBerkelhammerDLLoramLCRozeskeRRBlandSTMaierSFGleesonTTWatkinsLRMinocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances" exact="systemic" post="morphine-induced analgesiaBrain Behav Immun2008221248125618706994 HutchinsonMRLewisSSCoatsBDSkybaDACrysdaleNYBerkelhammerDLBrzeskiANorthcuttAVietzCMJuddCMMaierSFWatkinsLRJohnsonKWReduction of opioid withdrawal and"/>
  <result pre="analgesiaBrain Behav Immun2008221248125618706994 HutchinsonMRLewisSSCoatsBDSkybaDACrysdaleNYBerkelhammerDLBrzeskiANorthcuttAVietzCMJuddCMMaierSFWatkinsLRJohnsonKWReduction of opioid withdrawal and potentiation of" exact="acute" post="opioid analgesia by systemic AV411 (ibudilast)Brain Behav Immun20092324025018938237 HutchinsonMRet"/>
  <result pre="Immun2008221248125618706994 HutchinsonMRLewisSSCoatsBDSkybaDACrysdaleNYBerkelhammerDLBrzeskiANorthcuttAVietzCMJuddCMMaierSFWatkinsLRJohnsonKWReduction of opioid withdrawal and potentiation of acute opioid" exact="analgesia" post="by systemic AV411 (ibudilast)Brain Behav Immun20092324025018938237 HutchinsonMRet al.Evidence that"/>
  <result pre="of opioid withdrawal and potentiation of acute opioid analgesia by" exact="systemic" post="AV411 (ibudilast)Brain Behav Immun20092324025018938237 HutchinsonMRet al.Evidence that opioids may"/>
  <result pre="analysesTrends Pharmacol Sci20052631131715925706 IndelicatoRAPortenoyRKOpioid rotation in the management of refractory" exact="cancer" post="painJournal of clinical oncology : official journal of the"/>
  <result pre="cancer painJournal of clinical oncology : official journal of the" exact="American" post="Society of Clinical Oncology20022034835211773191 IversJHFitzgeraldJWhelanCSweeneyBKeenanEFaganAMcMarrowJMeanyJBarryJFrodlTProgressive white matter impairment as"/>
  <result pre="Murray J, Byrd DA, Hurd YL, Morgello S (2013) HIV-related" exact="cognitive impairment" post="shows bi-directional association with dopamine receptor DRD1 and DRD2"/>
  <result pre="polymorphisms in substance-dependent and substance-independent populations. J Neurovirol 19:495â€&quot;504 JankovicBDHorvatJDjordjijevicDRamahAFridmanVSpahicOBrain-associated" exact="autoimmune" post="features in heroin addicts: correlation to HIV infection and"/>
  <result pre="Neurovirol 19:495â€&quot;504 JankovicBDHorvatJDjordjijevicDRamahAFridmanVSpahicOBrain-associated autoimmune features in heroin addicts: correlation to" exact="HIV infection" post="and dementiaThe International journal of neuroscience1991581131261938173 Jaureguiberry-BravoMWilsonRCarvalloLBermanJWOpioids and opioid"/>
  <result pre="19:495â€&quot;504 JankovicBDHorvatJDjordjijevicDRamahAFridmanVSpahicOBrain-associated autoimmune features in heroin addicts: correlation to HIV" exact="infection" post="and dementiaThe International journal of neuroscience1991581131261938173 Jaureguiberry-BravoMWilsonRCarvalloLBermanJWOpioids and opioid"/>
  <result pre="HIV NeuropathogenesisCurr HIV Res20161441743027009099 JeevanjeeSPenkoJGuzmanDMiaskowskiCBangsbergDRKushelMBOpioid analgesic misuse is associated with" exact="incomplete" post="antiretroviral adherence in a cohort of HIV-infected indigent adults"/>
  <result pre="and biased receptor signalingJ Pharmacol Exp Ther201133629630221030484 KhalsaJVocciFAlticeFFiellinDMillerVBuprenorphine and HIV" exact="primary" post="care: new opportunities for integrated treatmentClin Infect Dis200643Suppl 4S169S17217109302"/>
  <result pre="transportClin Pharmacol Drug Dev2017612513428263461 Khatri UG, Perrone J (2020) Opioid" exact="use disorder" post="and COVID-19: crashing of the crises. J Addict Med"/>
  <result pre="15:285 Kimura-KurodaJNagashimaKYasuiKInhibition of myelin formation by HIV-1 gp120 in rat" exact="cerebral" post="cortex cultureArch Virol199413781997526826 KishSJKalasinskyKSDerkachPSchmunkGAGuttmanMAngLAdamsVFurukawaYHaycockJWStriatal dopaminergic and serotonergic markers in"/>
  <result pre="(1996) Î¼-Opioid receptor activation enhances DNA synthesis in immature oligodendrocytes." exact="Brain" post="Res 743:341â€&quot;345 Knapp PE, Maderspach K, Hauser KF (1998)"/>
  <result pre="evaluation of the impact of active efflux by P-glycoprotein and" exact="breast cancer" post="resistance protein at the blood-brain barrier on the predictability"/>
  <result pre="of the impact of active efflux by P-glycoprotein and breast" exact="cancer" post="resistance protein at the blood-brain barrier on the predictability"/>
  <result pre="efflux by P-glycoprotein and breast cancer resistance protein at the" exact="blood-brain barrier" post="on the predictability of the unbound concentrations of drugs"/>
  <result pre="the predictability of the unbound concentrations of drugs in the" exact="brain" post="using cerebrospinal fluid concentration as a surrogate. J Pharmacol"/>
  <result pre="neurocircuitry analysisLancet Psychiatry2016376077327475769 KostrikisLGHuangYMooreJPWolinskySMZhangLGuoYDeutschLPhairJNeumannAUHoDDA chemokine receptor CCR2 allele delays HIV-1" exact="disease" post="progression and is associated with a CCR5 promoter mutationNat"/>
  <result pre="of hyperphosphorylated tau and p62-positive inclusionsNeurobiol Aging2015363100310726254956 Kramer-HammerleSRothenaignerIWolffHBellJEBrack-WernerRCells of the" exact="central nervous system" post="as targets and reservoirs of the human immunodeficiency virusVirus"/>
  <result pre="central nervous system as targets and reservoirs of the human" exact="immunodeficiency" post="virusVirus Res200511119421315885841 Krathwohl MD, Kaiser JL (2004) HIV-1 promotes"/>
  <result pre="Anal Toxicol1996203693788889672 KumarROrsoniSNormanLVermaASTiradoGGiavedoniLDStapransSMillerGMBuchSJKumarAChronic morphine exposure causes pronounced virus replication in" exact="cerebral" post="compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian"/>
  <result pre="critical modulators of drug use and abuseNeuropsychopharmacology20174215617727402494 LamaJPlanellesVHost factors influencing" exact="susceptibility to" post="HIV infection and AIDS progressionRetrovirology200745217651505 LangfordTDLetendreSLMarcotteTDEllisRJJAMCGrantIMalloryMEHansenLAArchibaldSJerniganTMasliahEcollab: Group HSevere, demyelinating"/>
  <result pre="of drug use and abuseNeuropsychopharmacology20174215617727402494 LamaJPlanellesVHost factors influencing susceptibility to" exact="HIV infection" post="and AIDS progressionRetrovirology200745217651505 LangfordTDLetendreSLMarcotteTDEllisRJJAMCGrantIMalloryMEHansenLAArchibaldSJerniganTMasliahEcollab: Group HSevere, demyelinating leukoencephalopathy in"/>
  <result pre="drug use and abuseNeuropsychopharmacology20174215617727402494 LamaJPlanellesVHost factors influencing susceptibility to HIV" exact="infection" post="and AIDS progressionRetrovirology200745217651505 LangfordTDLetendreSLMarcotteTDEllisRJJAMCGrantIMalloryMEHansenLAArchibaldSJerniganTMasliahEcollab: Group HSevere, demyelinating leukoencephalopathy in"/>
  <result pre="susceptibility to HIV infection and AIDS progressionRetrovirology200745217651505 LangfordTDLetendreSLMarcotteTDEllisRJJAMCGrantIMalloryMEHansenLAArchibaldSJerniganTMasliahEcollab: Group HSevere," exact="demyelinating" post="leukoencephalopathy in AIDS patients on antiretroviral therapyAIDS2002161019102911953468 Lapierre J,"/>
  <result pre="to HIV infection and AIDS progressionRetrovirology200745217651505 LangfordTDLetendreSLMarcotteTDEllisRJJAMCGrantIMalloryMEHansenLAArchibaldSJerniganTMasliahEcollab: Group HSevere, demyelinating" exact="leukoencephalopathy" post="in AIDS patients on antiretroviral therapyAIDS2002161019102911953468 Lapierre J, Rodriguez"/>
  <result pre="deficient mouse. J NeuroImmune Pharmacol 13:355â€&quot;370 LawlorPGThe panorama of opioid-related" exact="cognitive dysfunction" post="in patients with cancer: a critical literature appraisalCancer2002941836185311920548 Lawrence"/>
  <result pre="Schwartz L, Seth P, Maric D, Major EO (2004) Human" exact="immunodeficiency" post="virus type 1 infection of human brain-derived progenitor cells."/>
  <result pre="Seth P, Maric D, Major EO (2004) Human immunodeficiency virus" exact="type 1" post="infection of human brain-derived progenitor cells. J Virol 78:7319â€&quot;7328"/>
  <result pre="Maric D, Major EO (2004) Human immunodeficiency virus type 1" exact="infection" post="of human brain-derived progenitor cells. J Virol 78:7319â€&quot;7328 Lee"/>
  <result pre="production and Cdk5 regulation. J Neurovirol 19:418â€&quot;431 LeibrandCRParisJJGhandourMSKnappPEKimWKHauserKFMcRaeMHIV-1 tat disrupts" exact="blood-brain barrier" post="integrity and increases phagocytic perivascular macrophages and microglia in"/>
  <result pre="(2019) HIV-1 Tat and opioids act independently to limit antiretroviral" exact="brain" post="concentrations and reduce blood-brain barrier integrity. J Neurovirol 25:560â€&quot;577"/>
  <result pre="opioids act independently to limit antiretroviral brain concentrations and reduce" exact="blood-brain barrier" post="integrity. J Neurovirol 25:560â€&quot;577 LeiteSCCorreaDGDoringTMKuboTTNettoTMFerraciniRVenturaNBahiaPRGasparettoELDiffusion tensor MRI evaluation of"/>
  <result pre="tensor MRI evaluation of the corona radiata, cingulate gyri, and" exact="corpus callosum" post="in HIV patientsJ Magn Reson Imaging2013381488149323559497 LemonsADeGrooteNPerezACrawJNyakuMBrozDMattsonCLBeerLOpioid misuse among"/>
  <result pre="callosum in HIV patientsJ Magn Reson Imaging2013381488149323559497 LemonsADeGrooteNPerezACrawJNyakuMBrozDMattsonCLBeerLOpioid misuse among" exact="HIV-positive" post="adults in medical care: results from the medical monitoring"/>
  <result pre="273:7024â€&quot;7029 Leppla IE, Gross MS (2020) Optimizing medication treatment of" exact="opioid use disorder" post="during COVID-19 (SARS-CoV-2). J Addict Med 14:e1â€&quot;e3. 10.1097/ADM.0000000000000678. Lerner"/>
  <result pre="Leppla IE, Gross MS (2020) Optimizing medication treatment of opioid" exact="use disorder" post="during COVID-19 (SARS-CoV-2). J Addict Med 14:e1â€&quot;e3. 10.1097/ADM.0000000000000678. Lerner"/>
  <result pre="is clade dependent. J Neurosci 28:12190â€&quot;12198 LiWLiQZhuJQinYZhengYChangHZhangDWangHWangLWangYWangWWhite matter impairment in" exact="chronic" post="heroin dependence: a quantitative DTI studyBrain Res20131531586423895765 LiGHAndersonCJaegerLDoTMajorEONathACell-to-cell contact"/>
  <result pre="Li GH, Maric D, Major EO, Nath A (2020) Productive" exact="HIV infection" post="in astrocytes can be established via a non-classical mechanism."/>
  <result pre="GH, Maric D, Major EO, Nath A (2020) Productive HIV" exact="infection" post="in astrocytes can be established via a non-classical mechanism."/>
  <result pre="mechanism. AIDS 34:963â€&quot;978 LiangDYClarkJDModulation of the NO/CO-cGMP signaling cascade during" exact="chronic" post="morphine exposure in miceNeurosci Lett2004365737715234476 LiuRPaxtonWAChoeSCeradiniDMartinSRHorukRMacDonaldMEStuhlmannHKoupRALandauNRHomozygous defect in HIV-1"/>
  <result pre="HIV-1 infectionCell1996863673778756719 LiuHet al.Polymorphism in RANTES chemokine promoter affects HIV-1" exact="disease" post="progressionProc Natl Acad Sci U S A1999964581458510200305 LiuYLiuHKimBOGattoneVHLiJNathABlumJHeJJCD4-independent infection"/>
  <result pre="HIV-1 disease progressionProc Natl Acad Sci U S A1999964581458510200305 LiuYLiuHKimBOGattoneVHLiJNathABlumJHeJJCD4-independent" exact="infection" post="of astrocytes by human immunodeficiency virus type 1: requirement"/>
  <result pre="Sci U S A1999964581458510200305 LiuYLiuHKimBOGattoneVHLiJNathABlumJHeJJCD4-independent infection of astrocytes by human" exact="immunodeficiency" post="virus type 1: requirement for the human mannose receptorJ"/>
  <result pre="concentration and plasma free concentration as a surrogate measurement for" exact="brain" post="free concentrationDrug Metab Dispos2006341443144716760229 LiuWTHanYLiuYPSongAABarnesBSongXJSpinal matrix metalloproteinase-9 contributes to"/>
  <result pre="dependence on morphine in miceJ Neurosci2010307613762320519536 LiuBLiuXTangSJInteractions of opioids and" exact="HIV infection" post="in the pathogenesis of chronic painFront Microbiol2016710326903982 Liu H,"/>
  <result pre="on morphine in miceJ Neurosci2010307613762320519536 LiuBLiuXTangSJInteractions of opioids and HIV" exact="infection" post="in the pathogenesis of chronic painFront Microbiol2016710326903982 Liu H,"/>
  <result pre="LiuBLiuXTangSJInteractions of opioids and HIV infection in the pathogenesis of" exact="chronic" post="painFront Microbiol2016710326903982 Liu H, Xu E, Liu J, Xiong"/>
  <result pre="H (2016b) Oligodendrocyte injury and pathogenesis of HIV-1-associated neurocognitive disorders." exact="Brain" post="Sci 6:23 Liu H, Liu J, Xu E, Tu"/>
  <result pre="Tu G, Guo M, Liang S, Xiong H (2017) Human" exact="immunodeficiency" post="virus protein Tat induces oligodendrocyte injury by enhancing outward"/>
  <result pre="a systematic review and meta-analysisClin Infect Dis2016631094110427343545 LuZXuJRossiGCMajumdarSPasternakGWPanYXMediation of opioid" exact="analgesia" post="by a truncated 6-transmembrane GPCRJ Clin Invest20151252626263026011641 MacArthurGJMinozziSMartinNVickermanPDerenSBruneauJDegenhardtLHickmanMOpiate substitution"/>
  <result pre="(2008) Tight junction regulation by morphine and HIV-1 Tat modulates" exact="blood-brain barrier" post="permeability. J Clin Immunol 28:528â€&quot;541 Malik S, Khalique H,"/>
  <result pre="NeuroImmune Pharmacol2014934035324469921 MarcarioJKRiaziMAdanyIKenjaleHFlemingKMarquisJNemonOMayoMSYankeeTNarayanOCheneyPDEffect of morphine on the neuropathogenesis of SIVmac" exact="infection" post="in Indian rhesus macaquesJ NeuroImmune Pharmacol20083122518247128 MarcarioJKPendyalaGRiaziMFlemingKMarquisJCallenSLiscoSJFowlerSCCheneyPDBuchSJEffects of morphine"/>
  <result pre="and women. J NeuroVirol 24:488â€&quot;497 MartinEMGonzalezRVassilevaJBecharaADouble dissociation of HIV and" exact="substance use disorder" post="effects on neurocognitive tasks dependent on striatal integrityAIDS2019331863187031259761 Martin-ThormeyerEMPaulRHDrug"/>
  <result pre="women. J NeuroVirol 24:488â€&quot;497 MartinEMGonzalezRVassilevaJBecharaADouble dissociation of HIV and substance" exact="use disorder" post="effects on neurocognitive tasks dependent on striatal integrityAIDS2019331863187031259761 Martin-ThormeyerEMPaulRHDrug"/>
  <result pre="on neurocognitive tasks dependent on striatal integrityAIDS2019331863187031259761 Martin-ThormeyerEMPaulRHDrug abuse and" exact="hepatitis C" post="infection as comorbid features of HIV associated neurocognitive disorder:"/>
  <result pre="tasks dependent on striatal integrityAIDS2019331863187031259761 Martin-ThormeyerEMPaulRHDrug abuse and hepatitis C" exact="infection" post="as comorbid features of HIV associated neurocognitive disorder: neurocognitive"/>
  <result pre="A novel GÎ²Î³-subunit inhibitor selectively modulates Î¼-opioid-dependent antinociception and attenuates" exact="acute" post="morphine-induced antinociceptive tolerance and dependence. J Neurosci 28:12183â€&quot;12189 Matsunaga"/>
  <result pre="receptor OPRM1 gene with proinflammatory cytokine levels and health perception." exact="Brain" post="Behav Immun 23:931â€&quot;935 MattioliTALeduc-PessahHSkelhorne-GrossGNicolCJMilneBTrangTCahillCMToll-like receptor 4 mutant and null"/>
  <result pre="who inject drugs in UkraineJ Acquir Immune Defic Syndr20187928829530312275 McArthurJCSteinerJSacktorNNathAHuman" exact="immunodeficiency" post="virus-associated neurocognitive disorders: mind the gapAnn Neurol20106769971420517932 McCance-KatzEFTreatment of"/>
  <result pre="Neurol20106769971420517932 McCance-KatzEFTreatment of opioid dependence and coinfection with HIV and" exact="hepatitis C" post="virus in opioid-dependent patients: the importance of drug interactions"/>
  <result pre="Alcohol Depend20079126927817643869 McDermottDHBeecroftMJKleebergerCAAl-SharifFMOllierWEZimmermanPABoatinBALeitmanSFDetelsRHajeerAHMurphyPMChemokine RANTES promoter polymorphism affects risk of both" exact="HIV infection" post="and disease progression in the multicenter AIDS cohort studyAIDS2000142671267811125885"/>
  <result pre="Depend20079126927817643869 McDermottDHBeecroftMJKleebergerCAAl-SharifFMOllierWEZimmermanPABoatinBALeitmanSFDetelsRHajeerAHMurphyPMChemokine RANTES promoter polymorphism affects risk of both HIV" exact="infection" post="and disease progression in the multicenter AIDS cohort studyAIDS2000142671267811125885"/>
  <result pre="RANTES promoter polymorphism affects risk of both HIV infection and" exact="disease" post="progression in the multicenter AIDS cohort studyAIDS2000142671267811125885 McDonoughRJMaddenJJFalekAShaferDAPlineMGordonDBokosPKuehnleJCMendelsonJAlteration of"/>
  <result pre="studyAIDS2000142671267811125885 McDonoughRJMaddenJJFalekAShaferDAPlineMGordonDBokosPKuehnleJCMendelsonJAlteration of T and null lymphocyte frequencies in the" exact="peripheral" post="blood of human opiate addicts: in vivo evidence for"/>
  <result pre="by naloxone and cyclic nucleotidesNIDA Res Monogr1981341591656783926 McLaneVDCaoLWillisCLMorphine increases hippocampal" exact="viral" post="load and suppresses frontal lobe CCL5 expression in the"/>
  <result pre="correlate to suppressed hippocampal iNOS RNA expression and an absent" exact="type 1" post="interferon response in LP-BM5 murine AIDSJ Neuroimmunol201831911712929526406 McLennan GP,"/>
  <result pre="with a more rapid CD4 cell decline among treatment naive" exact="HIV-positive" post="patients in IndonesiaJ Int AIDS Soc2014171884424388495 MeijerinkHIndratiARSoedarmoSUtamiFde JongCAAlisjahbanaBvan CrevelRWisaksanaRVan"/>
  <result pre="associated with higher expression of CCR5 on CD4+ cells and" exact="lower" post="ex-vivo production of CCR5 ligandsAIDS20152938538825834861 MengJSindbergGMRoySDisruption of gut homeostasis"/>
  <result pre="CCR5 ligandsAIDS20152938538825834861 MengJSindbergGMRoySDisruption of gut homeostasis by opioids accelerates HIV" exact="disease" post="progressionFront Microbiol2015664326167159 MeyerUAZangerUMMolecular mechanisms of genetic polymorphisms of drug"/>
  <result pre="infectionHeadache19993931015613188 MishraRSinghSKHIV-1 tat C phosphorylates VE-cadherin complex and increases human" exact="brain" post="microvascular endothelial cell permeabilityBMC Neurosci2014158024965120 MishraMVetrivelSSiddappaNBRangaUSethPClade-specific differences in neurotoxicity"/>
  <result pre="human brain microvascular endothelial cell permeabilityBMC Neurosci2014158024965120 MishraMVetrivelSSiddappaNBRangaUSethPClade-specific differences in" exact="neurotoxicity" post="of human immunodeficiency virus-1 B and C tat of"/>
  <result pre="endothelial cell permeabilityBMC Neurosci2014158024965120 MishraMVetrivelSSiddappaNBRangaUSethPClade-specific differences in neurotoxicity of human" exact="immunodeficiency" post="virus-1 B and C tat of human neurons: significance"/>
  <result pre="Taneja M, Malik S, Khalique H, Seth P (2010) Human" exact="immunodeficiency" post="virus type 1 Tat modulates proliferation and differentiation of"/>
  <result pre="Malik S, Khalique H, Seth P (2010) Human immunodeficiency virus" exact="type 1" post="Tat modulates proliferation and differentiation of human neural precursor"/>
  <result pre="NeuroVirol 16:355â€&quot;367 MoisesHCRusinKIMacdonaldRLMu- and kappa-opioid receptors selectively reduce the same" exact="transient" post="components of high-threshold calcium current in rat dorsal root"/>
  <result pre="neuronsJ Neurosci199414590359167931552 MoorePDimsdaleJEOpioids, sleep, and cancer-related fatigueMed Hypotheses200258778211863402 Morales OdiaYJinkaMZiaiWCSevere" exact="leukoencephalopathy" post="following acute oxycodone intoxicationNeurocrit Care201013939720440598 MorganMMChristieMJAnalysis of opioid efficacy,"/>
  <result pre="MoorePDimsdaleJEOpioids, sleep, and cancer-related fatigueMed Hypotheses200258778211863402 Morales OdiaYJinkaMZiaiWCSevere leukoencephalopathy following" exact="acute" post="oxycodone intoxicationNeurocrit Care201013939720440598 MorganMMChristieMJAnalysis of opioid efficacy, tolerance, addiction"/>
  <result pre="the nucleus accumbens in male heroin addicts: implications for deep" exact="brain" post="stimulationEur Arch Psychiatry Clin Neurosci201526564765326189034 MullerUJSchiltzKMawrinCDobrowolnyHFrodlTBernsteinHGBogertsBTruebnerKSteinerJTotal hypothalamic volume is"/>
  <result pre="heroin addictsEur Arch Psychiatry Clin Neurosci201826824324828534187 MullerUJMawrinCFrodlTDobrowolnyHBusseSBernsteinHGBogertsBTruebnerKSteinerJReduced volumes of the" exact="external" post="and internal globus pallidus in male heroin addicts: a"/>
  <result pre="vulnerability to social defeat stressNeuropsychopharmacology2019441876188531132785 NandhuMSNaijilGSmijinSJayanarayananSPauloseCSOpioid system functional regulation in" exact="neurological disease" post="managementJ Neurosci Res2010883215322120734417 NarasipuraSDKimSAl-HarthiLEpigenetic regulation of HIV-1 latency in"/>
  <result pre="to social defeat stressNeuropsychopharmacology2019441876188531132785 NandhuMSNaijilGSmijinSJayanarayananSPauloseCSOpioid system functional regulation in neurological" exact="disease" post="managementJ Neurosci Res2010883215322120734417 NarasipuraSDKimSAl-HarthiLEpigenetic regulation of HIV-1 latency in"/>
  <result pre="O (2014) Functions of the chemokine receptor CXCR in the" exact="central nervous system" post="and its regulation by Î¼-opioid receptors. Int Rev Neurobiol"/>
  <result pre="by Î¼-opioid receptors. Int Rev Neurobiol 118:105â€&quot;128 NathAPathobiology of human" exact="immunodeficiency" post="virus dementiaSemin Neurol19991911312710718533 Nath A (2015) Eradication of human"/>
  <result pre="immunodeficiency virus dementiaSemin Neurol19991911312710718533 Nath A (2015) Eradication of human" exact="immunodeficiency" post="virus from brain reservoirs. J NeuroVirol 21:227â€&quot;234 NathABoozeRMHauserKFMactutusCFBellJEMaragosWFBergerJRCritical questions"/>
  <result pre="Neurol19991911312710718533 Nath A (2015) Eradication of human immunodeficiency virus from" exact="brain" post="reservoirs. J NeuroVirol 21:227â€&quot;234 NathABoozeRMHauserKFMactutusCFBellJEMaragosWFBergerJRCritical questions for neuroscientists in"/>
  <result pre="psychiatry2018974230713510 Noel RJ Jr, Kumar A (2006) Virus replication and" exact="disease" post="progression inversely correlate with SIV Tat evolution in morphine-dependent"/>
  <result pre="macaques. Virology 346:127â€&quot;138 NoelRJJrKumarASIV Vpr evolution is inversely related to" exact="disease" post="progression in a morphine-dependent rhesus macaque model of AIDSVirology200735939740417064752"/>
  <result pre="of AIDSVirology200735939740417064752 NoelRJJrToro-BahamondeAMarrero-OteroZOrsiniSVermaASKumarRKumarALack of correlation between SIV-Nef evolution and rapid" exact="disease" post="progression in morphine-dependent nonhuman primate model of AIDSAIDS Res"/>
  <result pre="K, Nukuzuma C, Miyoshi I, Takegami T (2012) Exogenous human" exact="immunodeficiency" post="virus-1 protein, Tat, enhances replication of JC virus efficiently"/>
  <result pre="virus-1 protein, Tat, enhances replication of JC virus efficiently in" exact="neuroblastoma" post="cell lines. J Med Virol 84:555â€&quot;561 OehmichenMMeissnerCReiterABirkholzMNeuropathology in non-human"/>
  <result pre="neuroblastoma cell lines. J Med Virol 84:555â€&quot;561 OehmichenMMeissnerCReiterABirkholzMNeuropathology in non-human" exact="immunodeficiency" post="virus-infected drug addicts: hypoxic brain damage after chronic intravenous"/>
  <result pre="Virol 84:555â€&quot;561 OehmichenMMeissnerCReiterABirkholzMNeuropathology in non-human immunodeficiency virus-infected drug addicts: hypoxic" exact="brain damage" post="after chronic intravenous drug abuseActa Neuropathol1996916426468781664 OffiahCHallEHeroin-induced leukoencephalopathy: characterization"/>
  <result pre="in non-human immunodeficiency virus-infected drug addicts: hypoxic brain damage after" exact="chronic" post="intravenous drug abuseActa Neuropathol1996916426468781664 OffiahCHallEHeroin-induced leukoencephalopathy: characterization using MRI,"/>
  <result pre="using MRI, diffusion-weighted imaging, and MR spectroscopyClin Radiol20086314615218194689 OkamotoSKangYJBrechtelCWSivigliaERussoRClementeAHarropAMcKercherSKaulMLiptonSAHIV/gp120 decreases" exact="adult" post="neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal"/>
  <result pre="Tat and morphine: physiological allopregnanolone is protective against neurotoxic and" exact="psychomotor" post="effects. Neurobiol Stress 12:100211 PasternakGWMultiple opiate receptors: deja vu"/>
  <result pre="McRae M (2017) Effects of HIV-1 Tat and methamphetamine on" exact="blood-brain barrier" post="integrity and function in vitro. Antimicrob Agents Chemother 61:e01307-e1317"/>
  <result pre="penetration and the effects of HIV-1 Tat and morphine among" exact="primary" post="human brain endothelial cells, astrocytes, pericytes, and microglia. Neurosci"/>
  <result pre="the effects of HIV-1 Tat and morphine among primary human" exact="brain" post="endothelial cells, astrocytes, pericytes, and microglia. Neurosci Lett 712:134475"/>
  <result pre="J, Martinez C, Mellado M (2006) Opioids trigger Î±5Î²2 integrin-mediated" exact="monocyte" post="adhesion. J Immunol 176:1675â€&quot;1685 PendyalaGPeriyasamyPCallenSFoxHSLiscoSJBuchSJChronic SIV and morphine treatment"/>
  <result pre="J (2008) HIV-1-infected and/or immune-activated macrophage-secreted TNF-Î± affects human fetal" exact="cortical" post="neural progenitor cell proliferation and differentiation. Glia 56:903â€&quot;916 PengHSunLJiaBLanXZhuBWuYZhengJHIV-1-infected"/>
  <result pre="56:903â€&quot;916 PengHSunLJiaBLanXZhuBWuYZhengJHIV-1-infected and immune-activated macrophages induce astrocytic differentiation of human" exact="cortical" post="neural progenitor cells via the STAT3 pathwayPLoS One20116e1943921637744 Perez-CasanovaANoelRJJrRivera-AmillVHusainKKumarAMorphine-mediated"/>
  <result pre="pathwayPLoS One20116e1943921637744 Perez-CasanovaANoelRJJrRivera-AmillVHusainKKumarAMorphine-mediated deterioration of oxidative stress leads to rapid" exact="disease" post="progression in SIV/SHIV-infected macaquesAIDS Res Hum Retrovir2007231004100717725417 Perez-CasanovaAHusainKNoelRJJrRivera-AmillVKumarAInteraction of"/>
  <result pre="progression in SIV/SHIV-infected macaquesAIDS Res Hum Retrovir2007231004100717725417 Perez-CasanovaAHusainKNoelRJJrRivera-AmillVKumarAInteraction of SIV/SHIV" exact="infection" post="and morphine on plasma oxidant/antioxidant balance in macaqueMol Cell"/>
  <result pre="on plasma oxidant/antioxidant balance in macaqueMol Cell Biochem200830816917517934700 PetersPJet al.HIV" exact="infection" post="linked to injection use of oxymorphone in Indiana, 2014-2015N"/>
  <result pre="J Med201637522923927468059 PetersonPKSharpBMGekkerGPortoghesePSSannerudKBalfourHHJrMorphine promotes the growth of HIV-1 in human" exact="peripheral" post="blood mononuclear cell coculturesAIDS199048698732174676 PetersonPKGekkerGHuSSchoolovYBalfourHHJrChaoCCMicroglial cell upregulation of HIV-1"/>
  <result pre="the chronically infected promonocytic cell line U1: the role of" exact="tumor" post="necrosis factor-alphaJ Neuroimmunol19924181871460095 PetersonPKGekkerGSchutRHuSBalfourHHJrChaoCCEnhancement of HIV-1 replication by opiates"/>
  <result pre="PetersonPKMolitorTWChaoCCThe opioid-cytokine connectionJ Neuroimmunol19988363699610674 PetersonPKGekkerGHuSLokensgardJPortoghesePSChaoCCEndomorphin-1 potentiates HIV-1 expression in human" exact="brain" post="cell cultures: implication of an atypical mu-opioid receptorNeuropharmacology19993827327810218868 PettesTWoodEGuillemiSLaiCMontanerJKerrTMethadone"/>
  <result pre="HIV-1 expression in human brain cell cultures: implication of an" exact="atypical" post="mu-opioid receptorNeuropharmacology19993827327810218868 PettesTWoodEGuillemiSLaiCMontanerJKerrTMethadone use among HIV-positive injection drug users"/>
  <result pre="cultures: implication of an atypical mu-opioid receptorNeuropharmacology19993827327810218868 PettesTWoodEGuillemiSLaiCMontanerJKerrTMethadone use among" exact="HIV-positive" post="injection drug users in a Canadian settingJ Subst Abus"/>
  <result pre="planimetric and linear measurementsPsychiatry Res1998831391479849723 PitcherJAbtAMyersJHanRSnyderMGrazianoAFestaLKutzlerMGarciaFGaoWJFischer-SmithTRappaportJMeucciONeuronal ferritin heavy chain and" exact="drug abuse" post="affect HIV-associated cognitive dysfunctionJ Clin Invest201412465666924401274 Platt L, Reed"/>
  <result pre="2016:CD012021 Plotnikoff NP (1988) Opioids: immunomodulators. A proposed role in" exact="cancer" post="and aging. Ann N Y Acad Sci 521:312-322 PodhaizerEMZouSFittingSSamanoKLEl-HageNKnappPEHauserKFMorphine"/>
  <result pre="disposition of amprenavir (141W94), an HIV protease inhibitorPharm Res1999161206121210468021 PriceRWBrewBSidtisJRosenblumMScheckACClearyPThe" exact="brain" post="in AIDS: central nervous system HIV-1 infection and AIDS"/>
  <result pre="(141W94), an HIV protease inhibitorPharm Res1999161206121210468021 PriceRWBrewBSidtisJRosenblumMScheckACClearyPThe brain in AIDS:" exact="central nervous system" post="HIV-1 infection and AIDS dementia complexScience19882395865923277272 ProtassLMDelayed postanoxic encephalopathy"/>
  <result pre="inhibitorPharm Res1999161206121210468021 PriceRWBrewBSidtisJRosenblumMScheckACClearyPThe brain in AIDS: central nervous system HIV-1" exact="infection" post="and AIDS dementia complexScience19882395865923277272 ProtassLMDelayed postanoxic encephalopathy after heroin"/>
  <result pre="brain in AIDS: central nervous system HIV-1 infection and AIDS" exact="dementia" post="complexScience19882395865923277272 ProtassLMDelayed postanoxic encephalopathy after heroin useAnn Intern Med1971747387395559439"/>
  <result pre="nervous system HIV-1 infection and AIDS dementia complexScience19882395865923277272 ProtassLMDelayed postanoxic" exact="encephalopathy" post="after heroin useAnn Intern Med1971747387395559439 ProudnikovDRandesiMLevranOCrystalHDornMOttJHoAKreekMJAssociation of polymorphisms of"/>
  <result pre="of the mu opioid receptor gene with the severity of" exact="HIV infection" post="and response to HIV treatmentJ Infect Dis20122051745175622457278 ProudnikovDRandesiMLevranOYuferovVCrystalHHoAOttJKreekMJPolymorphisms of"/>
  <result pre="the mu opioid receptor gene with the severity of HIV" exact="infection" post="and response to HIV treatmentJ Infect Dis20122051745175622457278 ProudnikovDRandesiMLevranOYuferovVCrystalHHoAOttJKreekMJPolymorphisms of"/>
  <result pre="opioid receptor mRNA in dorsal root ganglia in response to" exact="peripheral" post="inflammation. Neuroscience 141:989â€&quot;998 PurohitVRapakaRSRutterJShurtleffDDo opioids activate latent HIV-1 by"/>
  <result pre="deficits in HIV-1 Tg26 transgenic miceJ Neuroinflammation20181528730314515 PutatundaRHoWZHuWHIV-1 and compromised" exact="adult" post="neurogenesis: emerging evidence for a new paradigm of HAND"/>
  <result pre="HAND persistenceAIDS Rev201921112230899112 QiuYJiangGSuHLvXZhangXTianJZhuoFProgressive white matter microstructure damage in male" exact="chronic" post="heroin dependent individuals: a DTI and TBSS studyPLoS One20138e6321223650554"/>
  <result pre="medical clinics of North America 88:751â€&quot;766 RadjaFKayDGAlbrechtSJolicoeurPOligodendrocyte-specific expression of human" exact="immunodeficiency" post="virus type 1 Nef in transgenic mice leads to"/>
  <result pre="of North America 88:751â€&quot;766 RadjaFKayDGAlbrechtSJolicoeurPOligodendrocyte-specific expression of human immunodeficiency virus" exact="type 1" post="Nef in transgenic mice leads to vacuolar myelopathy and"/>
  <result pre="virus type 1 Nef in transgenic mice leads to vacuolar" exact="myelopathy" post="and alters oligodendrocyte phenotype in vitroJ Virol200377117451175314557659 RaginABStoreyPCohenBAEpsteinLGEdelmanRRWhole brain"/>
  <result pre="vacuolar myelopathy and alters oligodendrocyte phenotype in vitroJ Virol200377117451175314557659 RaginABStoreyPCohenBAEpsteinLGEdelmanRRWhole" exact="brain" post="diffusion tensor imaging in HIV-associated cognitive impairmentAJNR Am J"/>
  <result pre="Edelman RR, Epstein LG (2005) Diffusion tensor imaging of subcortical" exact="brain" post="injury in patients infected with human immunodeficiency virus. J"/>
  <result pre="imaging of subcortical brain injury in patients infected with human" exact="immunodeficiency" post="virus. J Neurovirol 11(3):292â€&quot;298 RamageSNAnthonyICCarnieFWBusuttilARobertsonRBellJEHyperphosphorylated tau and amyloid precursor"/>
  <result pre="of young drug abusersNeuropathol Appl Neurobiol20053143944816008828 RangaUShankarappaRSiddappaNBRamakrishnaLNagendranRMahalingamMMahadevanAJayasuryanNSatishchandraPShankarSKPrasadVRTat protein of human" exact="immunodeficiency" post="virus type 1 subtype C strains is a defective"/>
  <result pre="drug abusersNeuropathol Appl Neurobiol20053143944816008828 RangaUShankarappaRSiddappaNBRamakrishnaLNagendranRMahalingamMMahadevanAJayasuryanNSatishchandraPShankarSKPrasadVRTat protein of human immunodeficiency virus" exact="type 1" post="subtype C strains is a defective chemokineJ Virol2004782586259014963162 RaoVRSasAREugeninEASiddappaNBBimonte-NelsonHBermanJWRangaUTyorWRPrasadVRHIV-1"/>
  <result pre="research and treatment2012201295367822666564 ReganPMDaveRSDattaPKKhaliliKEpigenetics of Âµ-opioid receptors: intersection with HIV-1" exact="infection" post="of the central nervous systemJ Cell Physiol20122272832284122034138 RittnerHLBrackAMachelskaHMousaSABauerMSchaferMSteinCOpioid peptide-expressing"/>
  <result pre="macaquesVirology201344614415124074576 Rivera-AmillVNoelRJJrOrsiniSTiradoGGarciaJMBuchSKumarAVariable region 4 of SIV envelope correlates with rapid" exact="disease" post="progression in morphine-exposed macaques infected with SIV/SHIVVirology200735837338317011009 Rivera-AmillVSilversteinPSNoelRJJrKumarSKumarAMorphine and"/>
  <result pre="progression in morphine-exposed macaques infected with SIV/SHIVVirology200735837338317011009 Rivera-AmillVSilversteinPSNoelRJJrKumarSKumarAMorphine and rapid" exact="disease" post="progression in nonhuman primate model of AIDS: inverse correlation"/>
  <result pre="progression in nonhuman primate model of AIDS: inverse correlation between" exact="disease" post="progression and virus evolutionJ NeuroImmune Pharmacol2010512213220013315 Rivera-Amill V, Noel"/>
  <result pre="Kumar A (2010b) Accelerated evolution of SIV env within the" exact="cerebral" post="compartment in the setting of morphine-dependent rapid disease progression."/>
  <result pre="within the cerebral compartment in the setting of morphine-dependent rapid" exact="disease" post="progression. Virology 398:201â€&quot;207 RobertsDWolfarthASanchezCPehrsonALFrontal cortex dysfunction as a target"/>
  <result pre="a target for remediation in opiate use disorder: role in" exact="cognitive dysfunction" post="and disordered reward systemsProg Brain Res201823917922730314567 Robinson-PappJMorgelloSVaidaFFitzsimonsCSimpsonDMElliottKJAl-LoziMGelmanBBCliffordDMarraCMMcCutchanJAAtkinsonJHDworkinRHGrantIEllisRAssociation of self-reported"/>
  <result pre="use disorder: role in cognitive dysfunction and disordered reward systemsProg" exact="Brain" post="Res201823917922730314567 Robinson-PappJMorgelloSVaidaFFitzsimonsCSimpsonDMElliottKJAl-LoziMGelmanBBCliffordDMarraCMMcCutchanJAAtkinsonJHDworkinRHGrantIEllisRAssociation of self-reported painful symptoms with clinical and"/>
  <result pre="HIV-associated sensory neuropathyPain201015173273620851521 Rodriguez SalgadoDRodriguez AlvarezMSeoane PesqueiraGNeuropsychological impairment among asymptomatic" exact="HIV-positive" post="former intravenous drug usersCogn Behav Neurol2006199510416783132 Rodriguez M, Lapierre"/>
  <result pre="F, El-Hage N (2017) Importance of autophagy in mediating human" exact="immunodeficiency" post="virus (HIV) and morphine-induced metabolic dysfunction and inflammation in"/>
  <result pre="opioid and chemokine receptorsAnn N Y Acad Sci2000917192811268344 RothenaignerIKramerSZieglerMWolffHKleinschmidtABrack-WernerRLong-term HIV-1" exact="infection" post="of neural progenitor populationsAIDS2007212271228118090275 RouveixBOpiates and immune function. Consequences"/>
  <result pre="of neural progenitor populationsAIDS2007212271228118090275 RouveixBOpiates and immune function. Consequences on" exact="infectious diseases" post="with special reference to AIDSTherapie1992475035121301643 RoySWangJKelschenbachJKoodieLMartinJModulation of immune function"/>
  <result pre="to AIDSTherapie1992475035121301643 RoySWangJKelschenbachJKoodieLMartinJModulation of immune function by morphine: implications for" exact="susceptibility to" post="infectionJ NeuroImmune Pharmacol20061778918040793 RoyalW3rdUpdikeMSelnesOAProctorTVNance-SprosonLSolomonLVlahovDCornblathDRMcArthurJCHIV-1 infection and nervous system abnormalities"/>
  <result pre="by morphine: implications for susceptibility to infectionJ NeuroImmune Pharmacol20061778918040793 RoyalW3rdUpdikeMSelnesOAProctorTVNance-SprosonLSolomonLVlahovDCornblathDRMcArthurJCHIV-1" exact="infection" post="and nervous system abnormalities among a cohort of intravenous"/>
  <result pre="interleukin-1Î²-mediated regulation of proenkephalin and opioid receptor messenger RNA in" exact="primary" post="astrocyte-enriched cultures. Neuroscience 79:517â€&quot;524 Ruzicka BB, Fox CA, Thompson"/>
  <result pre="CA, Thompson RC, Meng F, Watson SJ, Akil H (1995)" exact="Primary" post="astroglial cultures derived from several rat brain regions differentially"/>
  <result pre="Akil H (1995) Primary astroglial cultures derived from several rat" exact="brain" post="regions differentially express Î¼, Î´, and Îº opioid receptor"/>
  <result pre="regions differentially express Î¼, Î´, and Îº opioid receptor mRNA." exact="Brain" post="Res Mol Brain Res 34:209â€&quot;220 RyanLABresterMBohacDMorgelloSZhengJUp-regulation of soluble tumor"/>
  <result pre="Î¼, Î´, and Îº opioid receptor mRNA. Brain Res Mol" exact="Brain" post="Res 34:209â€&quot;220 RyanLABresterMBohacDMorgelloSZhengJUp-regulation of soluble tumor necrosis factor receptor"/>
  <result pre="mRNA. Brain Res Mol Brain Res 34:209â€&quot;220 RyanLABresterMBohacDMorgelloSZhengJUp-regulation of soluble" exact="tumor" post="necrosis factor receptor two in plasma of HIV-seropositive individuals"/>
  <result pre="compared with subtype A, in immunosuppressed individuals at risk of" exact="cognitive impairment" post="in Kampala, Uganda. Clin Infect Dis 49:780â€&quot;786 Salahuddin MF,"/>
  <result pre="D, Foster M, Vujanovic T, Box JG, Paris JJ (2020)" exact="Combined" post="HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal"/>
  <result pre="the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and" exact="cognitive dysfunction" post="in female mice. Horm Behav 119:104649 SalveminiDPeroxynitrite and opiate"/>
  <result pre="-gonadal axes and promote psychomotor, affective, and cognitive dysfunction in" exact="female" post="mice. Horm Behav 119:104649 SalveminiDPeroxynitrite and opiate antinociceptive tolerance:"/>
  <result pre="Reddy PV, Saiyed ZM, Nwankwo D, Nair MP (2011) Human" exact="immunodeficiency" post="virus type 1 clade B and C gp120 differentially"/>
  <result pre="Saiyed ZM, Nwankwo D, Nair MP (2011) Human immunodeficiency virus" exact="type 1" post="clade B and C gp120 differentially induce neurotoxin arachidonic"/>
  <result pre="JS, Schmidt BL, Maixner W, Dokholyan NV, Diatchenko L (2015)" exact="Structural" post="and functional interactions between six-transmembrane Î¼-opioid receptors and Î²2-adrenoreceptors"/>
  <result pre="States, 2013-2017MMWR Morb Mortal Wkly Rep2018671419142730605448 SchwartzLMajorEONeural progenitors and HIV-1-associated" exact="central nervous system disease" post="in adults and childrenCurr HIV Res2006431932716842084 SchwartzLCivitelloLDunn-PirioARyschkewitschSBerryECavertWKinzelNLawrenceDMHazraRMajorEOEvidence of human"/>
  <result pre="Mortal Wkly Rep2018671419142730605448 SchwartzLMajorEONeural progenitors and HIV-1-associated central nervous system" exact="disease" post="in adults and childrenCurr HIV Res2006431932716842084 SchwartzLCivitelloLDunn-PirioARyschkewitschSBerryECavertWKinzelNLawrenceDMHazraRMajorEOEvidence of human"/>
  <result pre="disease in adults and childrenCurr HIV Res2006431932716842084 SchwartzLCivitelloLDunn-PirioARyschkewitschSBerryECavertWKinzelNLawrenceDMHazraRMajorEOEvidence of human" exact="immunodeficiency" post="virus type 1 infection of nestin-positive neural progenitors in"/>
  <result pre="adults and childrenCurr HIV Res2006431932716842084 SchwartzLCivitelloLDunn-PirioARyschkewitschSBerryECavertWKinzelNLawrenceDMHazraRMajorEOEvidence of human immunodeficiency virus" exact="type 1" post="infection of nestin-positive neural progenitors in archival pediatric brain"/>
  <result pre="childrenCurr HIV Res2006431932716842084 SchwartzLCivitelloLDunn-PirioARyschkewitschSBerryECavertWKinzelNLawrenceDMHazraRMajorEOEvidence of human immunodeficiency virus type 1" exact="infection" post="of nestin-positive neural progenitors in archival pediatric brain tissueJ"/>
  <result pre="type 1 infection of nestin-positive neural progenitors in archival pediatric" exact="brain" post="tissueJ Neuro-Oncol200713274283 Secretary â€&quot; United States Department of Health"/>
  <result pre="public health emergency exists. https://www.hhs.gov/sites/default/files/opioid%20PHE%20Declaration-no-sig.pdf SerafiniRAPryceKDZachariouVThe mesolimbic dopamine system in" exact="chronic" post="pain and associated affective comorbiditiesBiol Psychiatry202087647331806085 SharmaHSAliSFAlterations in blood-brain"/>
  <result pre="in chronic pain and associated affective comorbiditiesBiol Psychiatry202087647331806085 SharmaHSAliSFAlterations in" exact="blood-brain barrier" post="function by morphine and methamphetamineAnn N Y Acad Sci2006107419822417105918"/>
  <result pre="S, Lokensgard JR, Peterson PK (2003) U50,488 inhibits HIV-1 Tat-induced" exact="monocyte" post="chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol"/>
  <result pre="gene specificity of neuropeptide gene expression in cultured astrocytesScience19892454154172569236 ShrotSPorettiATuckerEWSoaresBPHuismanTAAcute" exact="brain" post="injury following illicit drug abuse in adolescent and young"/>
  <result pre="gene expression in cultured astrocytesScience19892454154172569236 ShrotSPorettiATuckerEWSoaresBPHuismanTAAcute brain injury following illicit" exact="drug abuse" post="in adolescent and young adult patients: spectrum of neuroimaging"/>
  <result pre="brain injury following illicit drug abuse in adolescent and young" exact="adult" post="patients: spectrum of neuroimaging findingsNeuroradiol J20173014415028424016 SilbersteinCHO'DowdMAChartockPSchoenbaumEEFriedlandGHartelDMcKegneyFPA prospective four-year"/>
  <result pre="necessitate multiple preclinical modelsBiol Psychiatry201986e43e4531668223 SinghKKSpectorSAHost genetic determinants of human" exact="immunodeficiency" post="virus infection and disease progression in childrenPediatr Res20096555R63R19190524 SjogrenPThomsenABOlsenAKImpaired"/>
  <result pre="multiple preclinical modelsBiol Psychiatry201986e43e4531668223 SinghKKSpectorSAHost genetic determinants of human immunodeficiency" exact="virus infection" post="and disease progression in childrenPediatr Res20096555R63R19190524 SjogrenPThomsenABOlsenAKImpaired neuropsychological performance"/>
  <result pre="preclinical modelsBiol Psychiatry201986e43e4531668223 SinghKKSpectorSAHost genetic determinants of human immunodeficiency virus" exact="infection" post="and disease progression in childrenPediatr Res20096555R63R19190524 SjogrenPThomsenABOlsenAKImpaired neuropsychological performance"/>
  <result pre="Psychiatry201986e43e4531668223 SinghKKSpectorSAHost genetic determinants of human immunodeficiency virus infection and" exact="disease" post="progression in childrenPediatr Res20096555R63R19190524 SjogrenPThomsenABOlsenAKImpaired neuropsychological performance in chronic"/>
  <result pre="and disease progression in childrenPediatr Res20096555R63R19190524 SjogrenPThomsenABOlsenAKImpaired neuropsychological performance in" exact="chronic" post="nonmalignant pain patients receiving long-term oral opioid therapyJ Pain"/>
  <result pre="SmithMWDeanMCarringtonMWinklerCHuttleyGALombDAGoedertJJO'BrienTRJacobsonLPKaslowRBuchbinderSVittinghoffEVlahovDHootsKHilgartnerMWO'BrienSJContrasting genetic influence of CCR2 and CCR5 variants on HIV-1" exact="infection" post="and disease progression. Hemophilia growth and development study (HGDS),"/>
  <result pre="influence of CCR2 and CCR5 variants on HIV-1 infection and" exact="disease" post="progression. Hemophilia growth and development study (HGDS), multicenter AIDS"/>
  <result pre="and development study (HGDS), multicenter AIDS cohort study (MACS), multicenter" exact="hemophilia" post="cohort study (MHCS), San Francisco City Cohort (SFCC), ALIVE"/>
  <result pre="(SFCC), ALIVE studyScience19972779599659252328 Smith DB, Simmonds P, Bell JE (2014)" exact="Brain" post="viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive"/>
  <result pre="ALIVE studyScience19972779599659252328 Smith DB, Simmonds P, Bell JE (2014) Brain" exact="viral" post="burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting"/>
  <result pre="Smith DB, Simmonds P, Bell JE (2014) Brain viral burden," exact="neuroinflammation" post="and neurodegeneration in HAART-treated HIV positive injecting drug users."/>
  <result pre="HIV positive injecting drug users. J Neurovirol 20:28â€&quot;38 SolbrigMVKoobGFEpilepsy, CNS" exact="viral" post="injury and dynorphinTrends Pharmacol Sci2004259810415102496 SongCRahimRTDaveyPCBednarFBardiGZhangLZhangNOppenheimJJRogersTJProtein kinase CÎ¶ mediates"/>
  <result pre="Chem2011286203542036521454526 SorrellMEHauserKFLigand-gated purinergic receptors regulate HIV-1 tat and morphine related" exact="neurotoxicity" post="in primary mouse striatal neuron-glia co-culturesJ NeuroImmune Pharmacol2014923324424158495 Spruce"/>
  <result pre="purinergic receptors regulate HIV-1 tat and morphine related neurotoxicity in" exact="primary" post="mouse striatal neuron-glia co-culturesJ NeuroImmune Pharmacol2014923324424158495 Spruce BA, Curtis"/>
  <result pre="EMBO J 9(6):1787â€&quot;1795 SquintoSPMondalDBlockALPrakashOMorphine-induced transactivation of HIV-1 LTR in human" exact="neuroblastoma" post="cellsAIDS Res Hum Retrovir19906116311682252636 SteeleADSzaboIBednarFRogersTJInteractions between opioid and chemokine"/>
  <result pre="astrocytes: role of calcium in morphine-induced morphologic differentiationBrain Res Dev" exact="Brain" post="Res1993761891968149585 Stiene-Martin A, Zhou R, Hauser KF (1998) Regional,"/>
  <result pre="increased firm adhesion in an in vitro model of the" exact="blood-brain barrier." post="International journal of molecular sciences 17:916 Stubbe-DrgerBDeppeMMohammadiSKellerSSKugelHGregorNEversSYoungPRingelsteinEBArendtGKnechtSHusstedtIWGerman Competence NetworkHAEarly"/>
  <result pre="Neurol2012122322548835 SturdevantCBJosephSBSchnellGPriceRWSwanstromRSpudichSCompartmentalized replication of R5 T cell-tropic HIV-1 in the" exact="central nervous system" post="early in the course of infectionPLoS Pathog201511e100472025811757 SundarKSKamarajuLSDingfelderJMcMahonJGollapudiSWilsonWHKongLYHongJSWeissJMLeeJEÎ²-Endorphin enhances"/>
  <result pre="of infectionPLoS Pathog201511e100472025811757 SundarKSKamarajuLSDingfelderJMcMahonJGollapudiSWilsonWHKongLYHongJSWeissJMLeeJEÎ²-Endorphin enhances the replication of neurotropic human" exact="immunodeficiency" post="virus in fetal perivascular microgliaJ Neuroimmunol199561971047560019 SuomivuoriCMLatorracaNRWinglerLMEismannSKingMCKleinhenzALWSkibaMAStausDPKruseACLefkowitzRJDrorROMolecular mechanism of"/>
  <result pre="Neurodegener 6:78 Swan N (1997) CDC report highlights link between" exact="drug abuse" post="and spread of HIV. In: NIDA notes (AIDS research),"/>
  <result pre="morphine in ratsNeuroreport20182944144629465625 TaylorSDaviesSAntiretroviral drug concentrations in the male and" exact="female" post="genital tract: implications for the sexual transmission of HIVCurr"/>
  <result pre="place preference and the mu-opioid receptor-mediated dopamine increase in the" exact="posterior" post="nucleus accumbens of the ratEur J Pharmacol200858714715418448094 Theberge FR,"/>
  <result pre="MR, Rice KC, Watkins LR, Shaham Y (2013) Effect of" exact="chronic" post="delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on"/>
  <result pre="and their proper use as analgesics in the management of" exact="head and neck cancer" post="patientsAm J Otolaryngol20002124425410937910 ThompsonGLKellyEChristopoulosACanalsMNovel GPCR paradigms at the mu-opioid"/>
  <result pre="their proper use as analgesics in the management of head" exact="and neck" post="cancer patientsAm J Otolaryngol20002124425410937910 ThompsonGLKellyEChristopoulosACanalsMNovel GPCR paradigms at the"/>
  <result pre="use as analgesics in the management of head and neck" exact="cancer" post="patientsAm J Otolaryngol20002124425410937910 ThompsonGLKellyEChristopoulosACanalsMNovel GPCR paradigms at the mu-opioid"/>
  <result pre="without pre-symptomatic HIV infectionNeuropathol Appl Neurobiol19992536937910564526 TornatoreCMeyersKAtwoodWConantKMajorETemporal patterns of human" exact="immunodeficiency" post="virus type 1 transcripts in human fetal astrocytesJ Virol199468931028254781"/>
  <result pre="HIV infectionNeuropathol Appl Neurobiol19992536937910564526 TornatoreCMeyersKAtwoodWConantKMajorETemporal patterns of human immunodeficiency virus" exact="type 1" post="transcripts in human fetal astrocytesJ Virol199468931028254781 Torres-MunozJStocktonPTacoronteNRobertsBMaronpotRRPetitoCKDetection of HIV-1"/>
  <result pre="Nations Office on Drugs and Crime (UNODC). https://wdr.unodc.org/wdr2019/prelaunch/WDR19_Booklet_2_DRUG_DEMAND.pdf UpadhyayJMalekiNPotterJElmanIRudraufDKnudsenJWallinDPendseGMcDonaldLGriffinMAndersonJNutileLRenshawPWeissRBecerraLBorsookDAlterations in" exact="brain" post="structure and functional connectivity in prescription opioid-dependent patientsBrain20101332098211420558415 VaidyaNKRibeiroRMPerelsonASKumarAModeling"/>
  <result pre="prescription opioid-dependent patientsBrain20101332098211420558415 VaidyaNKRibeiroRMPerelsonASKumarAModeling the effects of morphine on simian" exact="immunodeficiency" post="virus dynamicsPLoS Comput Biol201612e100512727668463 van Rij RP, Portegies P,"/>
  <result pre="Roda Husman AM, van 't Wout AB, Schuitemaker H (1999)" exact="Reduced" post="prevalence of the CCR5 Î&quot;32 heterozygous genotype in human"/>
  <result pre="Reduced prevalence of the CCR5 Î&quot;32 heterozygous genotype in human" exact="immunodeficiency" post="virus-infected individuals with AIDS dementia complex. J Infect Dis"/>
  <result pre="CCR5 Î&quot;32 heterozygous genotype in human immunodeficiency virus-infected individuals with" exact="AIDS dementia complex." post="J Infect Dis 180:854â€&quot;857 VeenhuisRTClementsJEGamaLHIV eradication strategies: implications for"/>
  <result pre="Î&quot;32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS" exact="dementia" post="complex. J Infect Dis 180:854â€&quot;857 VeenhuisRTClementsJEGamaLHIV eradication strategies: implications"/>
  <result pre="180:854â€&quot;857 VeenhuisRTClementsJEGamaLHIV eradication strategies: implications for the central nervous systemCurr" exact="HIV/AIDS" post="Rep2019169610430734905 Venkatesan A, Nath A, Ming GL, Song H"/>
  <result pre="Rep2019169610430734905 Venkatesan A, Nath A, Ming GL, Song H (2007)" exact="Adult" post="hippocampal neurogenesis: regulation by HIV and drugs of abuse."/>
  <result pre="Trials Group study A5202J Antimicrob Chemother2014693300331025159623 Vestal-LabordeAAEschenroederACBigbeeJWRobinsonSESato-BigbeeCThe opioid system and" exact="brain" post="development: effects of methadone on the oligodendrocyte lineage and"/>
  <result pre="ligands at G-protein-coupled receptors: promise and progressTrends Pharmacol Sci20143530831624878326 VolkowNDMoralesMThe" exact="brain" post="on drugs: from reward to addictionCell201516271272526276628 VolkowNDFriedenTRHydePSChaSSMedication-assisted therapies--tackling the"/>
  <result pre="of buprenorphine: ceiling effects at high dosesClin Pharmacol Ther1994555695808181201 WangGJChangLVolkowNDTelangFLoganJErnstTFowlerJSDecreased" exact="brain" post="dopaminergic transporters in HIV-associated dementia patientsBrain20041272452245815319273 WangXLoramLCRamosKde JesusAJThomasJChengKReddyASomogyiAAHutchinsonMRWatkinsLRYinHMorphine activates"/>
  <result pre="at high dosesClin Pharmacol Ther1994555695808181201 WangGJChangLVolkowNDTelangFLoganJErnstTFowlerJSDecreased brain dopaminergic transporters in" exact="HIV-associated dementia" post="patientsBrain20041272452245815319273 WangXLoramLCRamosKde JesusAJThomasJChengKReddyASomogyiAAHutchinsonMRWatkinsLRYinHMorphine activates neuroinflammation in a manner parallel"/>
  <result pre="high dosesClin Pharmacol Ther1994555695808181201 WangGJChangLVolkowNDTelangFLoganJErnstTFowlerJSDecreased brain dopaminergic transporters in HIV-associated" exact="dementia" post="patientsBrain20041272452245815319273 WangXLoramLCRamosKde JesusAJThomasJChengKReddyASomogyiAAHutchinsonMRWatkinsLRYinHMorphine activates neuroinflammation in a manner parallel"/>
  <result pre="brain dopaminergic transporters in HIV-associated dementia patientsBrain20041272452245815319273 WangXLoramLCRamosKde JesusAJThomasJChengKReddyASomogyiAAHutchinsonMRWatkinsLRYinHMorphine activates" exact="neuroinflammation" post="in a manner parallel to endotoxinProc Natl Acad Sci"/>
  <result pre="A20121096325633022474354 WenHLuYYaoHBuchSMorphine induces expression of platelet-derived growth factor in human" exact="brain" post="microvascular endothelial cells: implication for vascular permeabilityPLoS One20116e2170721738771 WhelanPJRemskiKBuprenorphine"/>
  <result pre="growth factor in human brain microvascular endothelial cells: implication for" exact="vascular" post="permeabilityPLoS One20116e2170721738771 WhelanPJRemskiKBuprenorphine vs methadone treatment: a review of"/>
  <result pre="AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE study," exact="hemophilia" post="growth and development study (HGDS), multicenter AIDS cohort study"/>
  <result pre="and development study (HGDS), multicenter AIDS cohort study (MACS), multicenter" exact="hemophilia" post="cohort study (MHCS), San Francisco City Cohort (SFCC)Science19982793893939430590 WohlschlaegerJWengerEMehraeinPWeisSWhite"/>
  <result pre="into the CNS. J Neurovirol 6(Suppl 1):S82â€&quot;S85 WuYStoreyPCohenBAEpsteinLGEdelmanRRRaginABDiffusion alterations in" exact="corpus callosum" post="of patients with HIVAJNR Am J Neuroradiol20062765666016552012 WuHYTangXQMaoXFWangYXAutocrine Interleukin-10"/>
  <result pre="Front Neurosci 10:497 XuRFengXXieXZhangJWuDXuLHIV-1 tat protein increases the permeability of" exact="brain" post="endothelial cells by both inhibiting occludin expression and cleaving"/>
  <result pre="spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1PSynapse20146814415224375714 XuJLuZXuMPanLDengYXieXLiuHDingSHurdYLPasternakGWKleinRJCartegniLZhouWPanYXA" exact="heroin addiction" post="severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing"/>
  <result pre="OPRM1 via hnRNPH interactionsJ Neurosci201434110481106625122903 XuAHYangYSunYXZhangCDExogenous brain-derived neurotrophic factor attenuates" exact="cognitive impairment" post="induced by okadaic acid in a rat model of"/>
  <result pre="Res2018132173218130323150 XuanAWangGBShiDPXuJLLiYLInitial study of magnetic resonance diffusion tensor imaging in" exact="brain" post="white matter of early AIDS patientsChin Med J20131262720272423876903 YousifSSaubameaBCisterninoSMarie-ClaireCDauchySScherrmannJMDeclevesXEffect"/>
  <result pre="white matter of early AIDS patientsChin Med J20131262720272423876903 YousifSSaubameaBCisterninoSMarie-ClaireCDauchySScherrmannJMDeclevesXEffect of" exact="chronic" post="exposure to morphine on the rat blood-brain barrier: focus"/>
  <result pre="P-glycoproteinJ Neurochem200810764765718761714 YousifSChavesCPotinSMargaillIScherrmannJMDeclevesXInduction of P-glycoprotein and Bcrp at the rat" exact="blood-brain barrier" post="following a subchronic morphine treatment is mediated through NMDA/COX-2"/>
  <result pre="and OPRK1 mRNA expression in the anterior cingulate in postmortem" exact="brain" post="of HIV-infected subjectsJ Neuroinflammation201411524405578 Zhu C, Han Q, Samoshkin"/>
  <result pre="effects of HIV-1 Tat through actions at Î¼-opioid receptor-expressing glia." exact="Brain" post="134:3613â€&quot;3628 Zou S, Fuss B, Fitting S, Hahn YK,"/>
 </snippets>
</snippetsTree>
